ESAB (ESAB) 10-K 20 Feb 25 2024 FY Annual report Financial data

COVER PAGE

COVER PAGE - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Feb. 13, 2025	Jun. 28, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-41297
Entity Registrant Name	ESAB CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-0923837
Entity Address, Address Line One	909 Rose Avenue
Entity Address, Address Line Two	8th Floor
Entity Address, City or Town	North Bethesda
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	20852
City Area Code	301
Local Phone Number	323-9099
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	ESAB
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 5,707
Entity Common Stock Shares Outstanding		60,529,964
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Part III incorporates certain information by reference from the Registrant’s definitive proxy statement for its 2025 annual meeting of stockholders (the “2025 Proxy Statement”) to be filed pursuant to Regulation 14A within 120 days after the end of the Registrant’s fiscal year covered by this report. With the exception of the sections of the 2025 Proxy Statement specifically incorporated herein by reference, the 2025 Proxy Statement is not deemed to be filed as part of this Form 10-K.
Entity Central Index Key	0001877322
Amendment Flag	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024

AUDIT INFORMATION

AUDIT INFORMATION	12 Months Ended
	Dec. 31, 2024
Auditor Information [Abstract]
Auditor Name	Ernst & Young LLP
Auditor Location	Tysons, Virginia
Auditor Firm ID	42

CONSOLIDATED AND COMBINED STATE

CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 2,740,803	$ 2,774,766	$ 2,593,480
Cost of sales	1,703,348	1,759,015	1,707,950
Gross profit	1,037,455	1,015,751	885,530
Selling, general and administrative expense	579,778	587,475	533,369
Restructuring and other related charges	10,227	24,110	23,096
Operating income	447,450	404,166	329,065
Pension settlement loss (gain)	12,155	0	(9,136)
Interest expense and other, net	64,890	85,074	37,950
Income from continuing operations before income taxes	370,405	319,092	300,251
Income tax expense	77,348	95,727	69,170
Net income from continuing operations	293,057	223,365	231,081
Loss from discontinued operations, net of taxes	(22,309)	(12,341)	(3,068)
Net income	270,748	211,024	228,013
Income attributable to noncontrolling interest, net of taxes	(5,906)	(5,739)	(4,266)
Net income attributable to ESAB Corporation			$ 223,747
Net income attributable to ESAB Corporation	$ 264,842	$ 205,285
Earnings (loss) per share - basic
Income from continuing operations (in dollars per share)	$ 4.73	$ 3.59	$ 3.75
Loss on discontinued operations (in dollars per share)	(0.37)	(0.20)	(0.05)
Net income per share (in dollars per share)	4.36	3.39	3.70
Earnings (loss) per share - diluted
Income from continuing operations (in dollars per share)	4.68	3.56	3.74
Loss on discontinued operations (in dollars per share)	(0.37)	(0.20)	(0.05)
Net income per share - diluted (in dollars per share)	$ 4.31	$ 3.36	$ 3.69

CONSOLIDATED AND COMBINED STA_2

CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 270,748	$ 211,024	$ 228,013
Other comprehensive (loss) income:
Foreign currency translation, net of tax expense (benefit) of $6,141, $4,545 and $(2,930)	(108,472)	47,258	(175,719)
Unrealized (loss) gain on derivatives designated and qualifying as cash flow hedges, net of tax (benefit) expense of $(1,611), $(1,087) and $3,240	(5,554)	(3,732)	11,102
Defined benefit pension and other post-retirement plan activity, net of tax expense (benefit) of $2,458, $2,639 and $(1,840)	8,918	7,338	6,192
Other comprehensive (loss) income	(105,108)	50,864	(158,425)
Comprehensive income	165,640	261,888	69,588
Less: comprehensive income attributable to noncontrolling interest	4,394	5,887	678
Comprehensive income attributable to ESAB Corporation	$ 161,246	$ 256,001	$ 68,910

CONSOLIDATED AND COMBINED STA_3

CONSOLIDATED AND COMBINED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME [Parenthetical] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Foreign currency translation, tax expense (benefit)	$ 6,141	$ 4,545	$ (2,930)
Unrealized gain on derivatives designated and qualifying as cash flow hedges, net of tax expense (benefit)	(1,611)	(1,087)	3,240
Defined benefit pension and other post-retirement plan activity, net of tax expense (benefit)	$ 2,458	$ (2,639)	$ 1,840

CONSOLIDATED AND COMBINED BALAN

CONSOLIDATED AND COMBINED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 249,358	$ 102,003
Trade receivables, less allowance for credit losses of $23,850 and $25,477	370,321	385,198
Inventories, net	403,711	392,858
Prepaid expenses	55,665	61,771
Other current assets	69,327	55,890
Total current assets	1,148,382	997,720
Property, plant and equipment, net	298,347	294,305
Goodwill	1,651,993	1,588,331
Intangible assets, net	487,993	499,535
Lease asset - right of use	89,859	95,607
Other assets	357,401	353,131
Total assets	4,033,975	3,828,629
CURRENT LIABILITIES:
Current portion of long-term debt	15,000	0
Accounts payable	318,493	306,593
Accrued liabilities	298,558	313,489
Total current liabilities	632,051	620,082
Long-term debt	1,060,739	1,018,057
Other liabilities	532,936	542,833
Total liabilities	2,225,726	2,180,972
Equity:
Common stock - $0.001 par value - Authorized 600,000,000; 60,517,574 and 60,295,634 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively	61	60
Additional paid-in capital	1,901,337	1,881,054
Retained earnings	597,180	350,557
Accumulated other comprehensive loss	(729,574)	(624,272)
Total ESAB Corporation equity	1,769,004	1,607,399
Noncontrolling interest	39,245	40,258
Total equity	1,808,249	1,647,657
Total liabilities and equity	$ 4,033,975	$ 3,828,629

CONSOLIDATED AND COMBINED BAL_2

CONSOLIDATED AND COMBINED BALANCE SHEETS [Parenthetical] - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for credit losses	$ 23,850	$ 25,477
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	600,000,000	600,000,000
Common stock, shares issued (in shares)	60,517,574	60,295,634
Common stock, shares outstanding (in shares)	60,517,574	60,295,634

CONSOLIDATED AND COMBINED STA_4

CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Former Parent’s Investment	Accumulated Other Comprehensive Loss	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2021		0
Beginning balance at Dec. 31, 2021	$ 2,501,728	$ 0	$ 0	$ 0	$ 2,921,623	$ (460,888)	$ 40,993
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	228,013			168,310	55,437		4,266
Distributions and purchases relating to noncontrolling interest	(3,420)						(3,420)
Other comprehensive income (loss), net of tax	(158,425)					(154,837)	(3,588)
Dividends declared	(9,079)			(9,079)
Former Parent Common stock-based award activity	1,728				1,728
Net consideration paid to Former Parent, in connection with the Separation	(1,200,000)				(1,200,000)
Net Transfers from Former Parent, including Separation Adjustments	15,726		4,346		70,643	(59,263)
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent (in shares)		60,034,311,000
Issuance of common stock in connection with the Separation and reclassification of Net Investment from Former Parent	0	$ 60	1,849,371		(1,849,431)
Common stock-based award activity (in shares)		60,414,000
Common stock-based award activity	12,187		12,187
Ending balance (in shares) at Dec. 31, 2022		60,094,725,000
Ending balance at Dec. 31, 2022	$ 1,388,458	$ 60	1,865,904	159,231	0	(674,988)	38,251
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends on common stock (in dollars per share)	$ 0.15
Net income	$ 211,024			205,285			5,739
Distributions and purchases relating to noncontrolling interest	(3,880)						(3,880)
Other comprehensive income (loss), net of tax	50,864					50,716	148
Dividends declared	(13,959)			(13,959)
Common stock-based award activity (in shares)		200,909,000
Common stock-based award activity	$ 15,150		15,150
Ending balance (in shares) at Dec. 31, 2023	60,295,634	60,295,634,000
Ending balance at Dec. 31, 2023	$ 1,647,657	$ 60	1,881,054	350,557	0	(624,272)	40,258
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends on common stock (in dollars per share)	$ 0.23
Net income	$ 270,748			264,842			5,906
Distributions and purchases relating to noncontrolling interest	(4,253)		2,860			(1,706)	(5,407)
Other comprehensive income (loss), net of tax	(105,108)					(103,596)	(1,512)
Dividends declared	(18,219)			(18,219)
Common stock-based award activity (in shares)		221,940,000
Common stock-based award activity	$ 17,424	$ 1	17,423
Ending balance (in shares) at Dec. 31, 2024	60,517,574	60,517,574,000
Ending balance at Dec. 31, 2024	$ 1,808,249	$ 61	$ 1,901,337	$ 597,180	$ 0	$ (729,574)	$ 39,245
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends on common stock (in dollars per share)	$ 0.30

CONSOLIDATED AND COMBINED STA_5

CONSOLIDATED AND COMBINED STATEMENTS OF EQUITY [Parenthetical] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Other comprehensive income (loss), tax	$ (6,988)	$ 6,097	$ 1,530
Dividends on common stock (in dollars per share)	$ 0.30	$ 0.23	$ 0.15

CONSOLIDATED AND COMBINED STA_6

CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 270,748	$ 211,024	$ 228,013
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and other impairment charges	66,790	75,034	65,978
Stock-based compensation expense	19,780	16,122	12,964
Deferred income tax	(2,601)	(25,408)	(20,199)
Non-cash interest expense	2,886	1,195	1,972
Pension settlement loss (gain)	12,155	0	(9,136)
Changes in operating assets and liabilities:
Trade receivables, net	(4,848)	(6,006)	(8,142)
Inventories, net	(22,495)	17,958	(10,066)
Accounts payable	31,861	(19,819)	(28,794)
Other operating assets and liabilities	(18,877)	60,394	(18,232)
Net cash provided by operating activities	355,399	330,494	214,358
Cash flows from investing activities:
Purchases of property, plant and equipment	(51,779)	(48,178)	(40,243)
Proceeds from sale of property, plant and equipment	3,805	4,600	4,849
Acquisitions, net of cash received	(153,664)	(18,665)	(149,029)
Payments for (Proceeds from) Other Investing Activities	(4,058)	0	0
Net cash used in investing activities	(205,696)	(62,243)	(184,423)
Cash flows from financing activities:
Proceeds from borrowings on Senior Notes	700,000	0	0
Proceeds from borrowings on Term Loans	0	0	1,000,000
Repayments of borrowings on Term Loans	(602,500)	(12,500)	0
Proceeds from borrowings on revolving credit facility and other	205,000	574,150	805,881
Repayments of borrowings on revolving credit facility and other	(237,005)	(763,173)	(585,491)
Payment of debt issuance costs and other	(13,156)	(972)	(6,206)
Payment of dividends	(16,992)	(13,342)	(6,054)
Consideration to Former Parent in connection with the Separation	0	0	(1,200,000)
Distributions to noncontrolling interest holders	(3,678)	(3,880)	(3,420)
Transfers from Former Parent, net	0	0	2,847
Net cash provided by (used in) financing activities	31,669	(219,717)	7,557
Effect of foreign exchange rates on Cash and cash equivalents	(34,017)	(18,555)	(6,677)
Increase in Cash and cash equivalents	147,355	29,979	30,815
Cash and cash equivalents, beginning of period	102,003	72,024	41,209
Cash and cash equivalents, end of period	249,358	102,003	72,024
Supplemental disclosures:
Interest payments, net	62,280	79,148	34,678
Income tax payments, net	$ 94,525	$ 132,902	$ 85,659

Organization and Basis of Prese

Organization and Basis of Presentation	12 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Basis of Presentation	Organization and Basis of Presentation Founded in 1904, ESAB Corporation (“ESAB” or the “Company”) is a focused premier industrial compounder. ESAB provides its partners with fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company’s rich history of innovative products, workflow solutions and its business management system, ESAB Business Excellence (“EBX”), enables the Company’s purpose of Shaping the world we imagine TM . The Company’s products are utilized to solve challenges in a wide range of industries, including cutting, joining and automated welding. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter. Separation from Enovis On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax,” “Enovis” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the spin-off and related distribution, collectively, the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. As of the year ended December 31, 2022, Enovis no longer owned any of the Company’s outstanding common stock. In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Separation Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement and license agreement for EBX. Refer to Note 21, “Related Party Transactions” for further details. Russia and Ukraine Conflict The invasion of Ukraine by Russia and the sanctions imposed in response have increased the level of economic and political uncertainty. While ESAB continues to closely monitor the situation and evaluate options, the Company is meeting current contractual obligations while addressing applicable laws and regulations. For the year ended December 31, 2024, Russia represented approximately 5% of the Company’s total revenue, and approximately $13 million of its Net income. Excluding any goodwill allocation, Russia has approximately 4% of the Company’s total net assets as of December 31, 2024, including approximately $30 million of Cash and cash equivalents that may be subject to delays in withdrawing from Russia, based upon the current environment at that time. In case of the disposition of the Russia business, a portion of goodwill would need to be allocated and disposed of at the relative fair value attributable to the Russia business. Russia has a cumulative translation loss of approximately $130 million as of December 31, 2024, which could be realized upon a transition out. The Company is closely monitoring developments in Ukraine and Russia. Changes in laws and regulations or other factors impacting the Company’s ability to fulfill contractual obligations could have an adverse effect on the results of operations and cash flows. Basis of Presentation The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with generally accepted accounting principles in the United States (“GAAP”). The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation. The combined financial statements for the period prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Related party allocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.” Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Net Transfers from Former Parent, including Separation Adjustments” for the year ended December 31, 2022. For the periods subsequent to April 4, 2022, the financial statements are presented on a consolidated basis and no longer include any allocations of expenses from Enovis, as the Company became a standalone public company.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation The Company’s Consolidated and Combined Financial Statements include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest. All significant intercompany accounts and transactions have been eliminated. Equity Method Investments Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other-than-temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other-than-temporary, an impairment loss is recorded and the investment is written down to a new carrying value. Revenue Recognition The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services. The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers , to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time. As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 6, “Revenue” and Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances and related information. The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred. Taxes Collected from Customers and Remitted to Governmental Authorities The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated Balance Sheets until remitted to the respective taxing authority. Research and Development Expense Research and development costs of $39.2 million , $38.8 million and $36.0 million for the years ended December 31, 2024 , 2023 and 2022 , respectively, are expensed as incurred and are included in Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. These amounts do not include development and application engineering costs incurred in conjunction with fulfilling customer orders and executing customer projects. Cash and Cash Equivalents Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less. Trade Receivables Trade receivables are presented net of an allowance for credit losses. The estimate of current expected credit losses on trade receivables considers historical credit loss information that is adjusted for current conditions and reasonable and supportable forecasts. Estimated credit losses are reviewed periodically. Inventories Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. As of December 31, 2023 , cost for a substantial portion of United States inventories was determined using the last-in, first-out (“LIFO”) method. The value of inventory stated on a LIFO basis as of December 31, 2023 was $107.8 million and t he valuation of LIFO inventories was made at the end of the year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out (“FIFO”) method. During the fourth quarter of 2024 , the Company changed its inventory costing methodology from the previously disclosed LIFO method to the FIFO method for a portion of its inventory, as of the year ended December 31, 2024 all inventory is valued under FIFO. The Company performed this change because it believes FIFO is preferable given it provides a more consistent method for valuing inventory across the Company, better matches costs with revenues, improves comparability with peers and better reflects the current value of inventory at the balance sheet date. The LIFO expense for the years ended December 31, 2023 and 2022 were $2.1 million and $3.3 million, respectively which are not considered material to the Company’s financial statements. The Company recorded the pre-tax cumulative benefit related to this change in accounting principle of $4.3 million as a reduction of Cost of sales for the year ended December 31, 2024. Since these amounts are immaterial to all periods presented, the impact of this change was not retrospectively reflected in prior years. For further information, refer to Note 11, “Inventories, Net.” Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $41.2 million and $47.6 million as of December 31, 2024 and 2023, respectively. Property, Plant and Equipment Property, plant and equipment, net is stated at historical cost, which includes the fair values of such assets acquired through acquisitions and depreciated by the straight-line method over the estimated useful lives of the related assets. Repair and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset. Impairment of Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company. The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”). In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value. When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business. For the years ended December 31, 2024, 2023 and 2022, a qualitative Goodwill impairment assessment was performed for the three reporting units, all of which indicated no impairment existed and therefore, no impairment charges were recorded for the respective periods. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2024 annual impairment test. In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2024, 2023 and 2022, all of which indicated no impairment existed. Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from five The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The Company determined that no significant impairment indicators were evident during the years ended December 31, 2024, 2023 and 2022. Derivatives The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes. All derivatives are recognized at fair value on the Company’s Consolidated Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued. The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty. Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive loss ("AOCL") with offsetting amounts recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. Certain cross-currency swap agreements are designated and qualify as a net investment hedge. The changes in the fair value of these instruments are recorded in AOCL in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCL. Offsetting amounts are recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract. The Company has certain foreign currency contracts that are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense and other, net, in the Company’s Consolidated and Combined Statement of Operations. Warranty Costs Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency and average costs of warranty claims. Income Taxes Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The Company accounts for income taxes under ASC 740 , Income Taxes (“ASC 740”), which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income is accounted for as a current tax expense in the year the tax is incurred. Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets. The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations. Interest Expense and Other, Net Interest expense and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest expense of derivatives designated in hedging relationships. In addition, it is comprised of: • other non-operating expense (income) items, including certain pension-related activities, • foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships and • Argentina highly inflationary accounting transaction exchange loss on cash and cash equivalent remeasured into the Brazilian real - the direct parent’s currency. See “Foreign Currency Exchange Gains and Losses” and “Argentina Highly Inflationary Accounting” policies below for additional information. Foreign Currency Exchange Gains and Losses The Company’s Consolidated and Combined Financial Statements are presented in U.S. Dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation in Equity are net of income taxes to the extent the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year. Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated Balance Sheets are recognized in Selling, general and administrative expense or Interest expense and other, net in the Consolidated and Combined Statements of Operations for that period. The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations. Year Ended December 31, 2024 2023 2022 (In thousands) (1) Selling, general and administrative expense $ 7,136 $ 11,389 $ 2,597 Interest expense and other, net (158) 1,719 109 Foreign currency transaction loss, net (2) $ 6,978 $ 13,108 $ 2,706 (1) This table excludes the foreign currency exchange impacts of applying highly inflationary accounting for the Company’s Argentina operations, as described in the “Argentina Highly Inflationary Accounting” paragraph below. (2) During 2023, the weakening of the Ruble and certain South American currencies drove the increase in the loss on transactions denominated in foreign currencies. Argentina Highly Inflationary Accounting Argentina is deemed to have a highly inflationary economy, resulting in the remeasurement of the Company’s Argentinian operations into Brazilian real, the functional currency of the Argentinian entity’s direct parent. Gains and losses from the remeasurement are recorded in the Company’s Consolidated and Combined Statements of Operations. In December 2023, the Argentine peso significantly devalued due to changes in the foreign currency exchange policy introduced by the Argentine government. For the year ended December 31, 2024 , the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign currency exchange loss to Cost of sales of $8.9 million , Selling, general and administrative benefit of $0.6 million and Interest expense and other, net loss of $0.3 million . For the year ended December 31, 2023, the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign currency exchange loss to Cost of sales of $11.5 million, Selling, general and administrative benefit of $6.7 million and Interest expense and other, net loss of $26.2 million. For the year ended December 31, 2022 , the remeasurement of the financial statements of the Company’s subsidiary operating in a highly inflationary economy has resulted in a transaction foreign currency exchange loss to Cost of sales of $6.6 million , Selling, general and administrative expense of $3.3 million and Interest expense and other, net loss of $2.4 million . Use of Estimates The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined Financial Statements as well as material updates to previous assessments. Accounting Guidance Implemented in 2024 In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances segment reporting by expanding the breadth and frequency of disclosures through incremental information about significant segment expenses. The guidance also requires disclosure of the Chief Operating Decision Maker’s (the “CODM”) position and detail of how the CODM uses financial reporting to assess the segment’s performance. The new guidance is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024. The Company has adopted this guidance for the year ending December 31, 2024, and as discussed above, the primary impact is increased disclosure of certain financial information by segment. Refer to Note 20. “Segment Information” for further information on the impact on the Company’s disclosures. Recently Issued Accounting Guidance Not Yet Adopted In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures , which expands disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. The ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations The Company holds certain asbestos-related contingencies and insurance coverages from divested businesses that it does not have an interest in the ongoing operations. The Company has classified asbestos-related activity included in its Consolidated and Combined Statements of Operations as part of Loss from discontinued operations, net of taxes. This activity consists primarily of expected settlements, legal and administrative expenses associated with the above liabilities. Discontinued operations consist primarily of Selling, general and administrative expense, with an associated tax impact that is considered immaterial. See Note 19, “Commitments and Contingencies” for further information. Cash used in operating activities related to discontinued operations was $15.0 million, $15.2 million and $23.1 million for the years ended December 31, 2024, 2023 and 2022 , respectively.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions The Company continually evaluates potential acquisitions that either strategically fit with our existing portfolio or expand our portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for under the acquisition method of accounting. The Company makes an initial allocation of the purchase price at the date of acquisition based upon our understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains this information during due diligence and through other sources. As the Company obtains additional information about these assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, the Company is able to refine the estimates of fair value and more accurately allocate the purchase price. The Company makes appropriate adjustments to purchase price allocations prior to completion of the applicable measurement period, as required. The following describes our acquisition activity for the three years ended December 31, 2024. On October 31, 2024, the Company completed the acquisition of SUMIG Soluções para Solda e Corte Ltda., a South American light automation and equipment business for approximately $68 million, net of cash received, to open market opportunities and expand our portfolio in the Americas. The Company recognized intangible assets and goodwill of approximately $23 million and $37 million, respectively. On July 2, 2024, the Company completed the acquisition of ESAB Bangladesh Private Limited (formerly known as Linde Industries Private Limited), a leading welding company in Bangladesh, for approximately $69 million, net of cash received, to extend the Company’s position in this fast-growing region. The Company recognized intangible assets and goodwill of approximately $15 million and $46 million, respectively. On February 26, 2024, the Company completed the acquisition of Sager S.A., a welding repair and maintenance product and service leader in South America, for approximately $18 million, net of cash received, to expand our portfolio in the Company’s Americas region. On January 11, 2023, the Company completed the acquisition of Therapy Equipment Limited, a regional leader in oxygen regulators, for approximately $19 million, net of cash received, to strengthen the Company’s leading global gas control equipment portfolio. On October 31, 2022, the Company completed the acquisition of Swift Cut Automation Limited, a provider of light industrial cutting systems, for approximately $22 million, net of cash received. This acquisition provides a market-leading automated cutting portfolio. On October 14, 2022, the Company completed the acquisition of Ohio Medical, LLC, a United States based global leader in oxygen regulators and central gas systems, for approximately $127 million, net of cash received. This acquisition expands the Company’s presence in industrial specialty gas applications and products and broadens the Company’s United States presence. The Company recognized intangible assets and goodwill of approximately $50 million and $60 million, respectively.

Revenue

Revenue	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company provides fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. Substantially all revenue is recognized at a point in time. The Company disaggregates its revenue into the product groups included in the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Equipment $ 893,313 $ 854,949 $ 740,824 Consumables 1,847,490 1,919,817 1,852,656 Total $ 2,740,803 $ 2,774,766 $ 2,593,480 The sales mix in the above table is relatively consistent across both reportable segments. The consumables product grouping generally has less production complexity and shorter production cycles than equipment products. Given the nature of the business, the total amount of unsatisfied performance obligations with an original contract duration of greater than one year as of December 31, 2024 is immaterial. In some circumstances, customers are billed in advance of revenue recognition, resulting in contract liabilities. As of December 31, 2024, 2023 and 2022, total contract liabilities were $26.4 million , $31.2 million and $25.9 million, respectively, and are included in Accrued liabilities on the Consolidated Balance Sheets. During the years ended December 31, 2024 and 2023, substantially all amounts included in the contract liability balance at the beginning of the respective year were recognized as revenue in the following year. The table below summarizes the activity in the Company’s Allowance for credit losses included within Trade receivables in the Consolidated Balance Sheets. Year Ended December 31, 2024 Balance at Beginning of Period Charged to Expense, net Write-Offs and Deductions Foreign Currency Translation Balance at (In thousands) Allowance for credit losses $ 25,477 $ 2,248 $ (2,423) $ (1,452) $ 23,850

Earnings per Share from Continu

Earnings per Share from Continuing Operations	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings per Share from Continuing Operations	Earnings per Share from Continuing Operations The Company has unvested share-based payment awards with a right to receive non-forfeitable dividends that are considered participating securities. The table below summarizes how the Company allocates earnings to participating securities and computed earnings per share using the two-class method. Year Ended December 31, 2024 2023 2022 (In thousands, except share and per share data) Computation of earnings per share from continuing operations – basic: Income from continuing operations attributable to ESAB Corporation (1) $ 287,151 $ 217,626 $ 226,815 Less: distributed and undistributed earnings allocated to nonvested shares (1,370) (1,555) (1,600) Income from continuing operations attributable to common stockholders $ 285,781 $ 216,071 $ 225,215 Weighted-average shares of Common stock outstanding – basic 60,427,743 60,233,623 60,054,930 Income per share from continuing operations – basic $ 4.73 $ 3.59 $ 3.75 Computation of earnings (loss) per share from continuing operations – diluted: Income from continuing operations attributable to common stockholders $ 285,781 $ 216,071 $ 225,215 Weighted-average shares of Common stock outstanding – basic 60,427,743 60,233,623 60,054,930 Net effect of potentially dilutive securities (2) 674,320 422,123 98,129 Weighted-average shares of Common stock outstanding – dilution 61,102,063 60,655,746 60,153,059 Net income per share from continuing operations – diluted $ 4.68 $ 3.56 $ 3.74 (1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, o f $5.9 million, $5.7 million and $4.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. (2) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Separation from Enovis Prior to the Separation, our operating results were included in the Former Parent’s various consolidated United States federal and certain state income tax returns, as well as certain non-United States returns. For periods prior to the Separation, our combined financial statements reflect Income tax expense and deferred tax balances as if we had filed tax returns on a standalone basis separate from the Former Parent. The separate return method applies the accounting guidance for income taxes to the standalone financial statements as if we were a separate taxpayer and a standalone enterprise for the periods prior to the Separation. For periods prior to the Separation, our pretax operating results include any transactions with the Former Parent as if it were an unrelated party. In connection with the Separation, we entered into agreements with the Former Parent, including a Tax Matters Agreement. The Tax Matters Agreement distinguishes between the treatment of tax matters for “joint” filings compared to “separate” and “unitary state” filings prior to the Separation. “Joint” filings are returns, such as the United States federal return, which include operations from both Former Parent legal entities and the Company. By contrast, “separate” filings are tax returns (primarily United States state returns and non-United States returns) that exclusively include either the Former Parent’s or the Company’s operations. “Unitary state” filings are state tax returns, which may include legal entities of both the Company and the Former Parent. In accordance with the Tax Matters Agreement, the Company is liable for and has indemnified the Former Parent against all income tax liabilities involving “separate” and “unitary state” filings for periods prior to the Separation, except to the extent a unitary state filing includes a legal entity of the Former Parent and the adjustment relates to that legal entity. The Company is also liable for fifty percent of all cash taxes paid as a result of any adjustment or redetermination or otherwise in connection with any tax contest relating to any joint return. Additionally, under the Separation Agreement, the Company is responsible for any tax indemnity related to the discontinued operations by the Former Parent. Income from continuing operations before income taxes and Income tax expense consisted of the following per the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Income from continuing operations before income taxes: Domestic operations $ 50,212 $ 37,364 $ (19,234) Foreign operations 320,193 281,728 319,485 $ 370,405 $ 319,092 $ 300,251 Income tax expense: Current: Federal $ 15,717 $ 18,034 $ 8,928 State 2,635 3,760 2,451 Foreign 58,761 99,036 77,728 77,113 120,830 89,107 Deferred: Federal 2,489 (11,897) (7,501) State (126) (1,341) 358 Foreign (2,128) (11,865) (12,794) 235 (25,103) (19,937) $ 77,348 $ 95,727 $ 69,170 The Company’s Income tax expense differs from the amount that would be computed by applying the United States federal statutory rate as follows in the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Taxes calculated at the United States federal statutory rate $ 77,785 $ 67,010 $ 63,053 State taxes 1,956 1,630 2,809 Effect of tax rates on international operations 1,823 1,548 (9,010) Changes in tax reserves (4,206) 10,753 (350) Research and development tax credits (980) (714) (542) Effect of United States taxation on international operations 5,239 1,527 310 Permanent differences, net (4,061) 10,077 7,209 Provision to return (8,350) 703 (7,055) Withholding taxes 6,634 11,172 12,133 Capital gain — — (3,655) Valuation Allowance (761) (12,308) 4,503 Other 2,269 4,329 (235) Income tax expense $ 77,348 $ 95,727 $ 69,170 For the year ended December 31, 2024, the Company’s effective rate of 20.9% differs from the United States federal statutory rate of 21% due to favorable impacts from an agreement with a taxing authority on the treatment of subsidy income in a foreign jurisdiction, favorable changes in tax reserves primarily related to a final ruling in a tax case in a foreign jurisdiction, partially offset by withholding taxes. The Company’s effective tax rate of 30.0% for the year ended December 31, 2023 differed from the United States federal statutory rate of 21% due to changes in tax reserves, permanent differences relating to foreign subsidiaries and withholding taxes, partially offset by the favorable impact from changes in valuation allowances. The Company’s effective tax rate of 23.0% for the year ended December 31, 2022 differed from the United States federal statutory rate of 21% due to the impact of withholding taxes and permanent differences relating to foreign subsidiaries, partially offset by the favorable impact of the jurisdictional mix of income. Certain countries in which we operate have adopted Pillar Two legislation effective January 1, 2024. Pillar Two did not have a material impact on our 2024 effective tax rate. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. All deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets. The table below shows the temporary differences that gave rise to the significant components of deferred tax assets and liabilities. December 31, 2024 2023 (In thousands) Deferred tax assets: Post-retirement benefit obligation $ 1,229 $ 1,350 Expenses currently not deductible 59,518 52,526 Net operating loss carryforward 86,716 107,395 Tax credit carryforward 5,137 4,581 Depreciation and amortization 4,286 7,404 Inventory 10,795 12,238 Capitalized R&D costs 20,556 18,178 Leases 21,490 23,987 Other — 2,867 Valuation allowance (65,007) (79,355) Deferred tax assets, net $ 144,720 $ 151,171 Deferred tax liabilities: Depreciation and amortization $ (125,227) $ (120,055) Leases (22,084) (23,987) Outside basis differences and other (87,434) (79,985) Total deferred tax liabilities (234,745) (224,027) Total deferred tax liabilities, net $ (90,025) $ (72,856) Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets on a net jurisdictional basis as broken out in the table below. December 31, 2024 2023 (In thousands) Other assets $ 44,816 $ 46,602 Other liabilities (134,841) (119,458) Deferred tax liability, net $ (90,025) $ (72,856) The Company evaluates the recoverability of its deferred tax assets on a jurisdictional basis by considering whether deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely than not threshold, a valuation allowance is recorded. During the year ended December 31, 2024, the valuation allowance decreased from $79.4 million to $65.0 million primarily due to a net decrease in the valuation allowance and underlying deferred tax balance of $12.5 million. The decrease related to changes in the underlying deferred balances primarily relates to the reversal of the valuation allowance and the associated deferred balances in connection with a legal entity rationalization. In determining how much of the relevant deferred tax asset could be realized on a more likely than not basis, consideration was given to tax planning strategies and, when applicable, future taxable income. The Company has United States federal net operating loss carryforwards of $5.1 million as of December 31, 2024 expiring in years 2029 through 2036. The Company’s ability to use these various carryforwards to offset any taxable income generated in future taxable periods may be limited under Section 382 and other federal tax provisions. As of December 31, 2024 the Company also has $331.1 million foreign net operating loss carryforwards primarily in the United Kingdom, Germany and the Netherlands that may be subject to local tax restriction limitations. The foreign net operating losses can be carried forward indefinitely, except in applicable jurisdictions that make up less than five percent of the available net operating losses. During the year ended December 31, 2024, the Company has not made any material changes to its indefinite reinvestment assertion with respect to earnings reinvested in its foreign operations. The majority of our global unremitted foreign earnings have been taxed or would be exempt from United States tax upon repatriation. The Company has made no provision for United States income taxes or additional non-United States taxes on certain undistributed earnings or outside basis differences of non-United States subsidiaries in which the Company remains indefinitely reinvested. A portion of these undistributed earnings may be subject to foreign and United States tax consequences upon remittance. The Company cannot practically estimate the amount of additional taxes that might be payable on those undistributed earnings. The Company records a liability for certain unrecognized income tax benefits for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority (“uncertain tax positions”). This liability for such uncertain tax positions includes the amount of benefit included in (i) its previously filed income tax returns and (ii) its financial results expected to be included in income tax returns to be filed for periods through the date of its Consolidated and Combined Financial Statements. The Company’s total unrecognized tax benefits were $17.1 million, $30.9 million and $20.2 million as of December 31, 2024, 2023 and 2022, respectively, inclusive of $4.7 million, $12.1 million and $5.6 million, respectively, of interest and penalties. The Company records interest and penalties on uncertain tax positions as a component of Income tax expense, which was a benefit of $6.2 million, an expense of $7.9 million and a benefit of $0.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. The table below includes a reconciliation of the beginning and ending amount of gross unrecognized tax benefits (inclusive of associated interest and penalties). (In thousands) Balance, January 1, 2022 $ 37,681 Addition for tax positions taken in prior periods 1,971 Addition for tax positions taken in the current period 1,171 Reductions related to settlements with taxing authorities (922) Reductions resulting from a lapse of applicable statute of limitations (2,801) Other, including the impact of foreign currency translation and United States tax rate changes (16,897) Balance, December 31, 2022 20,203 Addition for tax positions taken in prior periods 13,514 Reductions related to settlements with taxing authorities (4,160) Transfer from Former Parent, impact of foreign currency translation and other (473) Other, including the impact of foreign currency translation and United States tax rate changes 1,787 Balance, December 31, 2023 30,871 Addition for tax positions taken in prior periods 6,436 Reductions for tax positions taken in prior periods (7,825) Reductions related to settlements with taxing authorities (9,255) Reductions resulting from a lapse of applicable statute of limitations (51) Other, including the impact of foreign currency translation (3,092) Balance, December 31, 2024 $ 17,084 The Company files numerous group and separate tax returns in Unites States federal and state jurisdictions, as well as international jurisdictions. The Company is routinely examined by various United States and non-United States taxing authorities. The Company is subject to audit by the United States, various states and foreign jurisdictions. In accordance with the Tax Matters Agreement with Former Parent, the Company is the primary obligor for (i) ESAB separate company state returns for all periods; (ii) unitary state returns that include only ESAB legal entities for all periods; and (iii) ESAB separate foreign returns for all periods. Pursuant to United States tax law, the Company filed its initial United States federal income tax return for the post-Separation period in October 2023. The Company reviews its global tax provisions on a quarterly basis. The Company accrues or adjusts contingent tax liabilities based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of the statutes of limitations. Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. The Company does not believe the total amount of unrecognized benefits will change by a material amount within the next 12 months due to the settlement of audits and expirations of statutes of limitations.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table summarizes Goodwill activity by segment for the years ended December 31, 2024 and 2023. Americas EMEA & APAC Total (In thousands) Balance, January 1, 2023 $ 585,845 $ 943,922 $ 1,529,767 Goodwill attributable to acquisition 1,664 13,912 15,576 Impact of foreign currency translation 2,366 40,622 42,988 Balance, December 31, 2023 589,875 998,456 1,588,331 Goodwill attributable to acquisitions 44,505 46,691 91,196 Impact of foreign currency translation (4,675) (22,859) (27,534) Balance, December 31, 2024 $ 629,705 $ 1,022,288 $ 1,651,993 The following table summarizes the Company’s Intangible assets, excluding Goodwill. December 31, 2024 2023 Gross Accumulated Gross Accumulated (In thousands) Indefinite-Lived Intangible Assets: Trade names $ 173,912 $ — $ 185,301 $ — Definite-Lived Intangible Assets: Customer relationships 506,226 (248,920) 496,483 (231,848) Technology 71,912 (55,539) 73,288 (55,288) Trade names 28,878 (11,832) 23,966 (10,983) Software 78,122 (62,391) 80,203 (61,920) Other intangible assets 30,424 (22,799) 22,878 (22,545) $ 889,474 $ (401,481) $ 882,119 $ (382,584) Amortization expense related to intangible assets of $36.0 million , $39.7 million and $35.6 million for the years ended December 31, 2024, 2023 and 2022, respectively, are included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. The Company’s expected annual amortization expense for acquired intangible assets for the next five years is as follows. December 31, 2024 (In thousands) 2025 $ 30,754 2026 29,231 2027 25,626 2028 22,828 2029 21,399

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	Property, Plant and Equipment, Net December 31, Depreciable Life 2024 2023 (In years) (In thousands) Land n/a $ 14,484 $ 15,095 Buildings and improvements 5-40 176,077 178,682 Machinery and equipment 3-15 409,045 394,318 599,606 588,095 Accumulated depreciation (301,259) (293,790) $ 298,347 $ 294,305 Depreciation expense for the years ended December 31, 2024 , 2023 and 2022 was $30.6 million , $30.0 million and $29.5 million, respectively.

Inventories, Net

Inventories, Net	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Inventories, Net	Inventories, Net December 31, 2024 2023 (In thousands) Raw materials $ 151,248 $ 156,583 Work in process 41,698 43,561 Finished goods 251,994 244,580 444,940 444,724 LIFO reserve — (4,279) Less: allowance for excess, slow-moving and obsolete inventory (41,229) (47,587) $ 403,711 $ 392,858 At December 31, 2023, approximately 27.4% of total inventories were valued using the LIFO method. During 2024, the Company changed its costing methodology to only using FIFO method, as the Company believes FIFO is preferable given it provides a more consistent method for valuing inventory across the Company, better matches costs with revenues, improves comparability with peers and better reflects the current value of inventory at the balance sheet date. Therefore, the Company recorded the pre-tax cumulative benefit related to this change in accounting principle of $4.3 million as a reduction of Cost of sales for the year ended December 31, 2024. Refer to Note 2, “Summary of Significant Accounting Policies” for further information regarding this change in accounting policy.

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases The Company leases certain office spaces, warehouses, production facilities, vehicles and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include renewal options, which can extend the lease term into the future. The Company determines the lease term by assuming options that are reasonably certain of being renewed will be exercised. Certain of the Company’s leases include rental payments adjusted for inflation. The right-of-use lease asset is recorded on the Consolidated Balance Sheets, with the current lease liability being included in Accrued liabilities and noncurrent lease liability being included in Other liabilities. Operating lease expense was $24.9 million, $25.4 million and $21.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. December 31, 2024 (In thousands) Future lease payments by year: 2025 $ 24,478 2026 17,555 2027 12,403 2028 9,861 2029 8,438 Thereafter 25,628 Total 98,363 Less: present value discount (10,862) Present value of lease liabilities $ 87,501 Weighted-average remaining lease term (in years): Operating leases 6.18 Weighted-average discount rate: Operating leases 4.4 %

Accrued and Other Liabilities

Accrued and Other Liabilities	12 Months Ended
	Dec. 31, 2024
Accrued Liabilities [Abstract]
Accrued and Other Liabilities	Accrued and Other Liabilities The table below includes a summarized breakout of Accrued and Other liabilities in the Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Current Noncurrent Current Noncurrent (In thousands) Accrued taxes and deferred tax liabilities $ 46,395 $ 151,642 $ 45,681 $ 144,662 Compensation and related benefits 80,451 48,350 97,052 52,589 Asbestos liability 40,779 253,287 32,908 234,796 Contract liability 26,390 — 31,248 — Lease liability 21,459 66,042 22,794 76,609 Warranty liability 12,794 — 12,606 — Third-party commissions 17,346 — 18,711 — Restructuring liability 4,732 374 5,345 354 Accrued interest 8,077 — 711 — Other 40,135 13,241 46,433 33,823 $ 298,558 $ 532,936 $ 313,489 $ 542,833 The table below summarizes the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated Balance Sheets. Year Ended December 31, 2024 2023 (In thousands) Warranty liability, beginning of period $ 12,606 $ 12,946 Accrued warranty expense 10,570 5,794 Changes in estimates related to pre-existing warranties 1,624 3,097 Cost of warranty service work performed (11,426) (10,710) Foreign exchange translation effect and other (580) 1,479 Warranty liability, end of period $ 12,794 $ 12,606 The Company’s restructuring programs include a series of actions to reduce the structural costs of the Company. The table below summarizes the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated Balance Sheets. Year Ended December 31, 2024 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 4,595 $ 4,538 $ (5,288) $ — $ 3,845 Facility closure costs and other (2) 1,104 5,689 (5,112) (420) 1,261 $ 5,699 $ 10,227 $ (10,400) $ (420) $ 5,106 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment and other costs in connection with the closure and optimization of facilities and product lines. Year Ended December 31, 2023 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 4,910 $ 10,017 $ (10,223) $ (109) $ 4,595 Facility closure costs (2) 2,908 8,637 (10,483) 42 1,104 Subtotal $ 7,818 18,654 $ (20,706) $ (67) $ 5,699 Non-cash charges (3) 5,456 $ 24,110 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expenses and other costs in connection with the closure and optimization of facilities and product lines. (3) Includes impairment of long-lived assets in connection with the closure and optimization of facilities and product lines.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Benefit Plans	Benefit Plans The Company sponsors various defined benefit plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. The other post-retirement benefit plans are immaterial. The Company uses December 31 st as the measurement date for all of its employee benefit plans. During the year ended December 31, 2024, the Company recognized a non-cash pension settlement loss of $12.2 million related to the transfer of plan assets to a third party as part of externalizing the risk associated with a foreign defined benefit plan. During the year ended December 31, 2022, the Company recognized a Pension settlement gain of $9.1 million related to a completed buy-out of a foreign defined benefit plan by a third party plus the merger of two Company pension plans resulting in one plan benefiting from the surplus assets in the other plan. These amounts are reflected in the Pension settlement loss (gain) line item in the Consolidated and Combined Statements of Operations. The following table summarizes the total changes in the Company’s total and foreign pension benefits and plan assets and includes a statement of the plans’ funded status. All Pension Benefits Foreign Pension Benefits Year Ended December 31, Year Ended December 31, 2024 2023 2024 2023 (In thousands) Change in benefit obligation: Projected benefit obligation, beginning of year $ 242,743 $ 256,022 $ 99,215 $ 99,401 Service cost 1,429 1,439 1,429 1,439 Interest cost 8,828 11,170 2,576 4,148 Plan amendments (9) 175 (9) 175 Actuarial (gain) loss (5,945) 802 1,178 335 Foreign exchange effect (5,386) 4,079 (5,386) 4,079 Benefits paid (21,242) (27,720) (4,561) (7,138) Settlements (31,583) (3,584) (31,583) (3,584) Other 1,039 360 1,039 360 Projected benefit obligation, end of year 189,874 242,743 63,898 99,215 Accumulated benefit obligation, end of year $ 186,689 $ 239,578 $ 60,713 $ 96,049 Change in plan assets: Fair value of plan assets, beginning of year $ 211,472 $ 219,050 $ 65,278 $ 70,821 Actual return on plan assets 12,389 19,651 2,024 1,262 Employer contributions (1) 4,309 (857) 4,175 (1,015) Foreign exchange effect (2,028) 3,162 (2,028) 3,162 Benefits paid (21,242) (27,720) (4,561) (7,138) Settlements (43,283) (2,505) (43,283) (2,505) Other 289 691 289 691 Fair value of plan assets, end of year 161,906 211,472 21,894 65,278 Funded status, end of year $ (27,968) $ (31,271) $ (42,004) $ (33,937) Amounts recognized on the Consolidated Balance Sheets as of December 31: Non-current assets $ 17,228 $ 17,300 $ 2,072 $ 13,426 Current liabilities (3,113) (3,186) (2,979) (3,052) Non-current liabilities (42,083) (45,385) (41,097) (44,311) $ (27,968) $ (31,271) $ (42,004) $ (33,937) (1) The employer contribution amount for the year ended December 31, 2023 includes a refund of assets totaling $5.1 million to the Company arising from a completed wind up of a foreign defined benefit plan. For pension plans with accumulated benefit obligations in excess of plan assets, the accumulated benefit obligation and fair value of plan assets were $49.3 million and $6.3 million, respectively, as of December 31, 2024 and $50.7 million and $3.9 million, respectively, as of December 31, 2023. For pension plans with projected benefit obligations in excess of plan assets, the projected benefit obligation and fair value of plan assets were $52.4 million and $7.2 million, respectively, as of December 31, 2024 and $55.6 million and $7.0 million, respectively, as of December 31, 2023. Expected contributions to the Company’s pension benefit plans for the year ending December 31, 2025 are $4.5 million. The table below includes the benefit payments that are expected to be paid during each respective fiscal year. Pension Benefits All Plans Foreign Plans (In thousands) 2025 $ 19,136 $ 5,735 2026 18,347 5,368 2027 17,986 5,455 2028 17,243 5,133 2029 16,917 5,309 2030 - 2034 76,386 26,156 The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The target allocation for plan assets varies by plan and jurisdiction. The table below shows the actual allocation percentages for the Company’s pension plan assets. Actual Asset Allocation 2024 2023 United States Plans: Equity securities: United States 37 % 38 % International 13 % 12 % Fixed income 50 % 49 % Cash and cash equivalents 0 % 1 % Foreign Plans: Equity securities 4 % 1 % Fixed income securities 15 % 48 % Cash and cash equivalents 1 % 1 % Insurance contracts 44 % 38 % Investment funds (1) 36 % 12 % (1) Represents various fixed income and equity securities. The table below summarizes the Company’s pension plan assets for each fair value hierarchy level for the periods presented (see Note 17, “Fai r Value Measurements” for further description of the levels within the fair value hierarchy). December 31, 2024 December 31, 2023 Measured at Net Asset Value (1) Level Level Level Measured at Net Asset Value (1) Level Level Level (In thousands) (In thousands) United States Plans: Cash and cash equivalents $ — $ 379 $ — $ — $ 379 $ — $ 1,237 $ — $ — $ 1,237 Equity securities: United States large cap 28,803 — — — 28,803 29,289 — — — 29,289 United States small/mid cap 9,456 13,481 — — 22,937 10,130 16,033 — — 26,163 International 17,566 — — — 17,566 18,078 — — — 18,078 Fixed income mutual funds: United States government and corporate 69,152 — — — 69,152 70,283 — — — 70,283 Other — 1,175 — — 1,175 — 1,145 — — 1,145 Foreign Plans: Cash and cash equivalents (2) — 238 — — 238 — 547 — — 547 Equity securities — 904 — — 904 — 921 — — 921 Non-United States government and corporate bonds — 3,198 — — 3,198 — 31,147 — — 31,147 Insurance contracts — — 9,608 — 9,608 — — 24,592 — 24,592 Investment funds — — 7,919 — 7,919 — — 8,050 — 8,050 Other — — 27 — 27 — — 20 — 20 $ 124,977 $ 19,375 $ 17,554 $ — $ 161,906 $ 127,780 $ 51,030 $ 32,662 $ — $ 211,472 (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. (2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets. The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the Company’s total and foreign defined benefit pension plans. All Pension Benefits Foreign Pension Benefits Year Ended December 31, Year Ended December 31, 2024 2023 2022 2024 2023 2022 (In thousands) Components of Net Periodic Benefit Cost (Income): Service cost $ 1,429 $ 1,439 $ 1,684 $ 1,429 $ 1,439 $ 1,684 Interest cost 8,828 11,170 5,874 2,576 4,148 2,161 Amortization 1,634 1,206 4,313 130 40 687 Settlement loss (gain) 12,155 — (9,114) 12,155 — (9,114) Other (179) — 92 (179) (331) 92 Expected return on plan assets (9,410) (11,391) (11,519) (1,038) (2,475) (2,063) Net periodic benefit cost (income) $ 14,457 $ 2,424 $ (8,670) $ 15,073 $ 2,821 $ (6,553) Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Transfer from Former Parent (1) $ — $ — $ 53,134 $ — $ — $ — Current year net actuarial (gain) loss (9,598) (7,021) 949 (483) 1,984 (12,262) Current year prior service cost (9) 175 862 (9) 175 862 Less amounts included in net periodic benefit cost: Amortization of net (loss) (1,676) (1,575) (4,340) (172) (78) (714) Settlement / divestiture / other loss (455) (1,079) (67) (454) (1,079) (67) Amortization of prior service cost 42 38 (1,067) 42 38 (1,067) Total recognized in Other comprehensive income $ (11,696) $ (9,462) $ 49,471 $ (1,076) $ 1,040 $ (13,248) (1) As part of the Separation, certain United States defined benefit plans, formerly sponsored by the Former Parent were transferred to the Company as of March 21, 2022 (“Transfer Date”). Each component of net periodic benefit cost (income) is included in the Company’s Consolidated and Combined Statements of Operations for the years ended December 31, 2024, 2023 and 2022. Service cost is included within Selling, general and administrative expense with the non-service costs net of expected return on plan assets and settlement loss (gain) included within Interest expense and other, net. Settlement loss (gain) is recorded within Pension settlement loss (gain) on the Company’s Consolidated and Combined Statement of Operations. The table below shows the components of net unrecognized pension benefit cost included in AOCL in the Consolidated Balance Sheets that have not been recognized as a component of net periodic benefit cost. Pension Benefits December 31, 2024 2023 (In thousands) Net actuarial loss $ 49,917 $ 61,573 Prior service income (122) (81) $ 49,795 $ 61,492 The key economic assumptions used in the measurement of the Company’s pension benefits are included in the table below. Pension Benefits December 31, 2024 2023 Weighted-average discount rate: All plans 4.8 % 4.4 % Foreign plans 3.7 % 3.9 % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.1 % 3.1 % (1) Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. The key economic assumptions used in the computation of net periodic benefit cost are as included in the table below. Pension Benefits Year Ended December 31, 2024 2023 2022 Weighted-average discount rate: All plans 4.4 % 4.6 % 2.2 % Foreign plans 3.9 % 4.3 % 1.9 % Weighted-average expected return on plan assets: All plans 5.1 % 5.0 % 4.8 % Foreign plans 4.4 % 4.1 % 3.2 % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.1 % 3.2 % 3.2 % (1) Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date. The expected long-term rate of return on plan assets is determined using the calculated value of plan assets, which is based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans. The Company maintains defined contribution plans covering certain union and non-union employees. The Company’s expense for the years ended December 31, 2024, 2023 and 2022 was $7.5 million, $7.6 million and $8.7 million, respectively.

Debt

Debt	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt The table below shows the components of the Company’s debt. December 31, 2024 2023 (In thousands) Term loans $ 385,000 $ 987,500 Senior unsecured notes 700,000 — Revolving credit facility — 32,000 Total debt 1,085,000 1,019,500 Current portion of long-term debt (15,000) — Unamortized deferred financing fees (9,261) (1,443) Long-term debt $ 1,060,739 $ 1,018,057 Senior Notes, Term Loans and Revolving Credit Facility On April 4, 2022, the Company entered into a credit agreement (as amended and restated from time-to-time, the “Credit Agreement”) in connection with the Separation. The Credit Agreement initially consisted of a $750 million revolving credit facility (the “Revolving Facility”) with a maturity date of April 4, 2027, a Term A-1 loan with an initial aggregate principal amount of $400 million (the “Term Loan A-1 Facility”), with a maturity date of April 4, 2027 and a $600 million 364-day senior term loan facility (the “Term Loan A-2 Facility”) with a maturity date of April 3, 2023. The Revolving Facility contains a $300 million foreign currency sublimit and a $50 million swing line loan sub-facility. On April 4, 2022, the Company drew down $1.2 billion available under the credit facilities made up of (i) $200 million under the Revolving Facility, (ii) $400 million under the Term Loan A-1 Facility and (iii) $600 million under the Term Loan A-2 Facility. The Company used these proceeds to make payments to Enovis of $1.2 billion, which was used as part of the consideration for the contribution of certain assets and liabilities to the Company by Enovis in connection with the Separation. On June 28, 2022, the Company amended and restated the Credit Agreement by entering into Amendment No. 2 to Credit Agreement (the “Credit Agreement Amendment”). The Credit Agreement Amendment provides for a $600 million term loan facility (the “Term Loan A-3 Facility,” collectively the “Term Facilities” with the Term A-1 Facility and Term A-2 Facility) with a maturity date of April 3, 2025 to refinance the Company’s existing Term Loan A-2 Facility. Also on June 28, 2022, the Company borrowed the entire $600 million under Term Loan A-3 Facility to fund the repayment of the Term Loan A-2 Facility. On April 9, 2024, the Company issued $700 million in aggregate principal amount of 6.25% senior notes due 2029 (the “Senior Notes”) governed by an indenture (the “Indenture”). The Senior Notes have a contractual maturity interest rate of 6.25% and maturity date of April 15, 2029. The Company used the net proceeds from the Senior Notes to pay off its Term Loan A-3 Facility and pay fees associated with the offering. As of December 31, 2024, the Credit Agreement and the Indenture consist of the following facilities: • A $750 million Revolving Facility with a maturity date of April 4, 2027 with zero dollars drawn; • A Term A-1 Facility with an aggregate principal amount of $385 million, with maturity dates through April 4, 2027; and • Senior Notes with an aggregate principal amount of $700 million with a maturity date of April 15, 2029. The Credit Agreement and the Indenture contain customary covenants. These covenants limit the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets, make investments or pay dividends. In addition, the Credit Agreement requires that the Company maintains certain financial covenants and the Company was in compliance with all of its debt covenants as of December 31, 2024. The Credit Agreement and the Indenture contain various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term A-1 Facility, Senior Notes and the Revolving Facility. Certain United States subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement and the Senior Notes. Loans made under the Term A-1 Facility will bear interest, at the election of the Company, at either the base rate (as defined in the Credit Agreement) or at the term Secured Overnight Financing Rate (“SOFR”) plus an adjustment (as defined in the Credit Agreement), in each case, plus the applicable interest rate margin. Loans made under the Revolving Facility will bear interest, at the election of the Company, at either the base rate or, (i) in the case of loans denominated in dollars, the term SOFR plus an adjustment or the daily simple SOFR plus an adjustment, (ii) in the case of loans denominated in Euros, the adjusted Euro Interbank Offered Rate (“EURIBOR”) and, (iii) in the case of loans denominated in sterling, Sterling Overnight Index Average (“SONIA”) plus an adjustment (as all such rates are defined in the Credit Agreement Amendment), in each case, plus the applicable interest rate margin. The applicable interest rate margin changes based upon the Company’s total leverage ratio (ranging from 1.125% to 1.750% or in the case of the base rate margin, 0.125% to 0.750%). Each swing line loan denominated in dollars will bear interest at the base rate plus the applicable interest rate margin. To manage exposures to currency exchange rates and interest rates arising in Long-term debt, the Company entered into interest rate and cross-currency swap agreements. Refer to Note 16, “Derivatives” for additional information. Other Indebtedness In addition to the debt agreements discussed above, the Company has the ability to incur approximately $50 million of indebtedness pursuant to certain uncommitted credit lines, consisting of an uncommitted credit line that the Company currently has in place that the Company has used from time to time in the past for short-term working capital needs. The Company is party to letter of credit facilities with an aggregate capacity of $107.0 million. Total letters of credit of $27.2 million were outstanding as of December 31, 2024. Deferred Financing Fees In total, the Company had deferred financing fees of $9.9 million included in its Consolidated Balance Sheets as of December 31, 2024, which will be charged to Interest expense and other, net, over the term of the related debt instruments. The costs associated with the Term Facilities and Senior Notes noted above will be amortized over the contractual term of the related facility and the costs associated with these will be amortized over the life of the Credit Agreement or the Indenture, respectively. Of the $9.9 million, $0.6 million of deferred financing fees relating to the Revolving Facility are included in Other assets and $9.3 million of deferred financing fees relating to the Term Facilities and Senior Notes are recorded as a contra-liability within Long-term debt. Other The Company’s minimum principal payments for the next five years are broken out in the table below. December 31, 2024 (in thousands) 2025 $ 15,000 2026 20,000 2027 350,000 2028 — 2029 700,000 Total debt (1) $ 1,085,000 (1) Total debt excludes $9.3 million of related unamortized deferred financing fees.

Derivatives

Derivatives	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives The Company uses derivative instruments to manage exposures to currency exchange rates and interest rates arising in connection with Long-term debt and the normal course of business. The Company has established policies and procedures that govern the risk management of these exposures. Both at inception and on an ongoing basis, the derivative instruments that qualify for hedge accounting are assessed as to their effectiveness, when applicable. The Company is subject to the credit risk of counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. None of the concentrations of risk with an individual counterparty was considered significant as of December 31, 2024. The Company does not expect any counterparties to fail to meet their obligations. The Company records derivatives in the Consolidated Balance Sheets at fair value. Cash Flow Hedges On July 14, 2022, the Company entered into two interest rate swap agreements to manage interest rate risk exposure. The aggregate notional amount of these contracts was $600 million, maturing in April 2025. These interest rate swap agreements utilized by the Company effectively modify the Company’s exposure to interest rate risk by converting a portion of the Company’s floating-rate debt to a fixed rate of 3.293%, plus a spread, thus reducing the impact of interest-rate changes on future interest expense. The applicable spread may vary between 1.125% to 1.750%, depending on the total leverage ratio of the Company. In March 2024, the Company settled one of the interest rate swaps associated with the Company’s floating-rate debt and received $5.5 million in connection with that settlement. The termination of the interest rate swap was related to the repayment of the Term A-3 Facility in April 2024. Refer to Note 15, “Debt” for further information. As this interest rate swap was designated as a cash flow hedge, $5.5 million was deferred in AOCL and is being recognized in earnings over the period the originally forecasted hedged transaction impacts earnings. The remaining $300 million swap is expected to continue to be hedged against the remaining floating-rate debt. For the remaining swap, the spread was 1.250% as of December 31, 2024. This agreement involves the receipt of floating-rate amounts in exchange for fixed-rate interest payments over the life of the agreement without an exchange of the underlying principal amount. This interest rate swap agreement is designated and qualifies as a cash flow hedge and as such, the gain or loss on the derivative instrument due to the change in fair value is reported as a component of AOCL and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. The Company did not have any ineffectiveness related to cash flow hedges during the year ended December 31, 2024. The cash inflows and outflows associated with the Company’s interest rate swap agreements designated as cash flow hedges are classified in cash flows from operating activities in the accompanying Consolidated and Combined Statements of Cash Flows. The Company expects a gain o f $0.7 million, net of tax, related to interest rate swap agreements to be reclassified from AOCL to earnings through such agreement’s maturity in April 2025 as the hedged transactions are realized. The expected gain to be reclassified is based on current forward rates in active markets as of December 31, 2024. The table below shows the effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations. Year Ended December 31, Derivative type (Gain) recognized in the Consolidated and Combined Statements of Operations 2024 2023 (In thousands) Interest rate swap agreement(s) Interest expense and other, net $ (9,104) $ (11,053) Net Investment Hedges On July 22, 2022, the Company entered into two cross-currency swap agreements, set to mature in April 2025, to partially hedge its net investment in its Euro denominated subsidiaries against adverse movements in exchange rates between the U.S. Dollar and the Euro. The cross-currency swap agreements included provisions to exchange fixed-rate payments in U.S. Dollar for fixed-rate payments in Euro and were designated and qualify as a net investment hedge. These contracts had a Euro aggregate notional amount of approximately €270 million and a U.S. Dollar aggregate notional amount of $275 million. Prior to the maturity of these two cross-currency swaps, on June 25, 2024, the Company de-designated these swaps and entered into four new cross-currency swaps for the same above notional amounts that mature in October 2026. On August 22, 2024, the Company entered into two additional cross-currency swap agreements, set to mature in October 2026. These contracts have a Euro aggregate notional amount of approximately €90 million and a U.S. dollar aggregate notional amount of $100 million. These swaps are designated and accounted for as a net investment hedge. The changes in the spot rate of these instruments are recorded in AOCL in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCL. The Company uses the spot method of assessing hedge effectiveness and as such, the initial value of the hedge components excluded from the assessment of effectiveness is recognized in the Interest expense and other, net line item in the Consolidated and Combined Statement of Operations under a systematic and rational method over the life of the cross-currency swap agreements. Any ineffective portions of net investment hedges are reclassified from AOCL into earnings during the period of change. Due to the de-designation transaction above on June 25, 2024, the Company will keep the balance in AOCL related to the original derivative for the duration that the investment is held. The Company did not have any ineffectiveness related to net investment hedges during the year ended December 31, 2024. The cash inflows and outflows associated with the excluded components of the Company’s cross-currency swap agreements designated as net investment hedges are classified in operating activities in the accompanying Consolidated and Combined Statements of Cash Flows. The table below shows the effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations. Year Ended December 31, Derivative type (Gain) recognized in the Consolidated and Combined Statements of Operations 2024 2023 Cross currency-swap agreements Interest expense and other, net $ (4,687) $ (4,779) The table below shows the fair value of the derivatives recognized in the Company’s Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Designated as hedging instruments Other Liabilities Other Assets Other Liabilities Other Assets (In thousands) Cross-currency swap agreements $ 1,830 $ — $ 22,232 $ — Interest rate swap agreement(s) — 842 — 9,522 Total $ 1,830 $ 842 $ 22,232 $ 9,522 Derivatives Not Designated as Hedging Instruments The Company has certain foreign currency contracts that are not designated as hedges. As of December 31, 2024 and December 31, 2023, the Company had foreign currency contracts related to purchases and sales with notional values of $178.7 million and $232.5 million, respectively. The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Company’s Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Not designated as hedging instruments Accrued Liabilities Other Current Assets Accrued Liabilities Other Current Assets (In thousands) Foreign currency contracts $ 379 $ 255 $ 596 $ 1,088 The amounts in the table above as of December 31, 2024 reflect the fair value of the Company’s foreign currency contracts on a net basis where allowable under master netting agreements. Had these amounts been recognized on a gross basis, the impact would have been a $0.4 million increase in Other current assets with a corresponding increase in Accrued liabilities. The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship: Year Ended December 31, Foreign currency contracts 2024 2023 2022 (In thousands) Change in unrealized (loss) gain $ (616) $ (1,023) $ 1,338 Realized gain (loss) (1) $ 1,490 $ (2,928) $ (17,601) (1) The year ended December 31, 2022 includes realized losses relating to certain corporate entities contributed to ESAB Corporation that are reflected within Interest expense and other, net, in the Consolidated and Combined Statements of Operations. These realized losses are offset by unrealized gains which are also reflected within Interest expense and other, net, in the Consolidated and Combined Statements of Operations.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company utilizes fair value measurement guidance prescribed by accounting standards to value its financial instruments. The guidance establishes a fair value hierarchy based on the inputs used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows: Level One: Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets. Level Two: Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. Level Three: Inputs to the valuation methodology are unobservable and significant to the fair value measurement. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future. A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is in the table below (see Note 14, “Benefit Plan s” for classification of the assets of the Company’s benefit plans within the fair value hierarchy). December 31, 2024 December 31, 2023 Level Level Level Total Level Level Level Total (In thousands) (In thousands) Assets: Cash equivalents $ 8,990 $ — $ — $ 8,990 $ 6,027 $ — $ — $ 6,027 Foreign currency contracts — 657 — 657 — 2,261 — 2,261 Interest rate swap agreement — 842 — 842 — 9,522 — 9,522 Deferred compensation plans — 5,242 — 5,242 — 3,488 — 3,488 $ 8,990 $ 6,741 $ — $ 15,731 $ 6,027 $ 15,271 $ — $ 21,298 Liabilities: Foreign currency contracts $ — $ 781 $ — $ 781 $ — $ 1,769 $ — $ 1,769 Cross-currency swap agreements — 1,830 — 1,830 — 22,232 — 22,232 Deferred compensation plans — 5,242 — 5,242 — 3,488 — 3,488 $ — $ 7,853 $ — $ 7,853 $ — $ 27,489 $ — $ 27,489 The Company’s cash equivalents consist of investments in foreign interest-bearing deposit accounts and foreign money market mutual funds that are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities. The Company measures the fair value of foreign currency contracts, cross-currency swap agreements and interest rate swap agreement(s) using Level Two inputs based on observable spot and forward rates in active markets. Additionally, the fair value of derivatives designated in hedging relationships includes a credit valuation adjustment to appropriately incorporate nonperformance risk for the Company and the respective counterparty. For the year ended December 31, 2024, the impact of the credit valuation adjustment on the Company’s derivatives is immaterial. Refer to Note 16, “Derivatives” for additional information. There were no transfers in or out of Level One, Two or Three during the years ended December 31, 2024 and 2023. Concentration of Credit Risk Financial instruments potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable. Concentrations of credit risk are considered to exist when there are amounts collectible from multiple counterparties with similar characteristics, which could cause their ability to meet contractual obligations to be similarly impacted by economic or other conditions. The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required when the Company deems n ecessary. There are no customers that represent more than 10% of the Company’s Trade receivables, net as of December 31, 2024 and 2023.

Equity

Equity	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Equity	Equity Share Repurchase Program On August 13, 2024, the Board of Directors authorized and approved a stock repurchase program to repurchase up to five million shares of the Company’s Common stock, par value $0.001 per share, from time-to-time on the open market, in privately negotiated transactions or as may otherwise be determined by the Company’s management in its discretion. No repurchases of the Company’s Common stock have been made through the year ended December 31, 2024. The timing and amount of any shares repurchased will be determined by the Company’s management based on its evaluation of market conditions, applicable legal requirements and other factors. There is no term associated with the repurchase authorization. Accumulated Other Comprehensive Loss The following table presents the changes in the balances of each component of AOCL including reclassifications out of AOCL for the years ended December 31, 2024, 2023 and 2022. All amounts are net of tax and noncontrolling interest, if any. Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Net Investment Hedges Cash Flow Hedges Total (In thousands) Balance at January 1, 2022 $ (21,196) $ (439,692) $ — $ — $ (460,888) Other comprehensive (loss) income before reclassifications: Amounts contributed by Former Parent (2) (50,504) (8,759) — — (59,263) Net actuarial gain 113 — — — 113 Foreign currency translation adjustment 1,712 (82,351) (8,336) — (88,975) Loss on long-term intra-entity foreign currency transactions — (83,105) — — (83,105) Unrealized gain on cash flow hedges — — — 10,782 10,782 Other comprehensive (loss) income before reclassifications (48,679) (174,215) (8,336) 10,782 (220,448) Amounts reclassified from Accumulated other comprehensive loss ((1)(3) 6,028 — — 320 6,348 Net current period Other comprehensive (loss) income (42,651) (174,215) (8,336) 11,102 (214,100) Balance at December 31, 2022 (63,847) (613,907) (8,336) 11,102 (674,988) Other comprehensive income (loss) before reclassifications: Net actuarial gain 8,969 — — — 8,969 Foreign currency translation adjustment (3,285) (11,143) (8,879) — (23,307) Gain on long-term intra-entity foreign currency transactions — 70,428 — — 70,428 Unrealized gain on cash flow hedges — — — 4,834 4,834 Other comprehensive income (loss) before reclassifications 5,684 59,285 (8,879) 4,834 60,924 Amounts reclassified from Accumulated other comprehensive loss (1)(3) (1,642) — — (8,566) (10,208) Net current period Other comprehensive income (loss) 4,042 59,285 (8,879) (3,732) 50,716 Balance at December 31, 2023 (59,805) (554,622) (17,215) 7,370 (624,272) Other comprehensive income (loss) before reclassifications: Net actuarial gain 9,069 — — — 9,069 Foreign currency translation adjustment 530 (137,599) 15,968 — (121,101) Gain on long-term intra-entity foreign currency transactions — 14,136 — — 14,136 Unrealized gain on cash flow hedges — — — 4,426 4,426 Other comprehensive income (loss) before reclassifications 9,599 (123,463) 15,968 4,426 (93,470) Amounts reclassified from Accumulated other comprehensive loss (1)(3) (146) — — (9,980) (10,126) Purchase related to noncontrolling interest — (1,706) — — (1,706) Net current period Other comprehensive income (loss) 9,453 (125,169) 15,968 (5,554) (105,302) Balance at December 31, 2024 $ (50,352) $ (679,791) $ (1,247) $ 1,816 $ (729,574) (1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14, “Benefit Plans” for additional details. (2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities that were part of the Corporate segment of the Former Parent and were transferred to ESAB Corporation in anticipation of the Separation. (3) The amounts on this line within the Cash Flow Hedges column are a component of Interest expense and other, net. See Note 16, “Derivatives,” for additional details. Share-Based Payments In connection with the Separation, the Company adopted the 2022 Omnibus Incentive Plan (the “Stock Plan”) that became effective upon the Separation. Outstanding equity awards of the Former Parent held by ESAB employees at the Separation date were converted into or replaced with awards of ESAB common stock under the Stock Plan, with the intent to maintain the economic value of the equity awards immediately before and after the Distribution. The terms of the equity awards period, exercisability and vesting schedule, as applicable, generally continued unchanged. Other than converted or replacement equity awards of ESAB issued in replacement of the Former Parent’s RSUs and stock options, the terms of the converted or replacement equity awards of ESAB (e.g., vesting date and expiration date) continued unchanged. For the three months ended April 1, 2022, $0.7 million of stock-based compensation expense was allocated to the Company. Following the Separation, the Company independently incurs stock compensation expenses as a stand-alone company. The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Stock Options Under the Stock Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the Company’s common stock on the date of grant. Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a straight-line basis over the requisite service period of the entire award. For the year ended December 31, 2024, the Stock-based compensation expense for the stock option awards was $2.7 million. As of December 31, 2024 , the Company had $2.4 million of unrecognized compensation expense related to stock option awards that will be recognized over a weighted-average period of 1.8 years. Restricted Stock Units During the year ended December 31, 2023 and 2022, the Company granted certain employees performance-based restricted stock units (“PRSUs”), the vesting of which is fully based on company specific performance metrics over a three-year performance period. The awards also have a service requirement that equals the respective performance periods. These PRSUs are valued at the market value of a share of common stock on the date of grant taking into consideration the probability of achieving the specified performance goal. The ultimate payout of PRSUs with a performance metric adjusts the cumulative expense based on its estimate and the percent of the requisite service period that has elapsed. During the year ended December 31, 2024, the Company granted certain employees PRSUs, the calculation of the final achievement of which is based on Company-specific performance metrics as well as a modifier for the Company’s total shareholder return ranking among a peer group over a three-year performance period. The awards also have a service requirement that equals the respective performance periods. The related compensation expense for each of the awards is recognized on a straight-line basis over the vesting period. For the year ended December 31, 2024, the Stock-based compensation expense for the PRSUs was $5.7 million. Under the Stock Plan, the Compensation Committee may also award RSUs to select executives, employees and outside directors, which typically vest over three years after the date of grant. With limited exceptions, the employee must remain in service until the vesting date. The Compensation Committee determines the terms and conditions of each award, including any restriction period and other criteria applicable to the awards. For the year ended December 31, 2024, the Stock-based compensation expense for the RSUs was $11.4 million . The activity of the Company’s PRSUs and RSUs is included in the table below. PRSUs RSUs Number of Units Weighted- Average Number of Units Weighted-Average Balance at December 31, 2023 143,875 $ 55.86 464,730 $ 55.21 Granted 56,767 100.33 122,155 95.23 Vested — — (191,802) 56.54 Forfeited and expired — — (21,463) 65.79 Balance at December 31, 2024 200,642 $ 68.44 373,620 $ 67.02 The fair value of shares vested during the year ended December 31, 2024 was $10.7 million . As of December 31, 2024 , the Company had $18.5 million of unrecognized compensation expense related to PRSU and RSU awards that will be recognized over a weighted-average period of 1.8 years.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Asbestos Contingencies Certain entities that became subsidiaries of ESAB Corporation in connection with the Separation are the legal obligor for certain asbestos obligations including long-term asbestos insurance assets, long-term asbestos insurance receivables, accrued asbestos liabilities, long-term asbestos liabilities, asbestos indemnity expenses, asbestos-related defense costs and asbestos insurance recoveries related to the asbestos obligations from the Former Parent’s other legacy industrial businesses. As a result, the Company holds certain asbestos-related contingencies and insurance coverages. These subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured or used with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers and were not manufactured by any of the Company’s, or Former Parent’s, subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained or used asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the United States Navy. The subs idiaries settle asbestos claims for amounts the Company considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years while the number of cases has steadily declined, except for 2024 when they have been substantially even versus prior year. The Company expects fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment. The Company has classified asbestos-related activity in Loss from discontinued operations in the Consolidated and Combined Statements of Operations. This is consistent with the Former Parent’s classification on the basis that, pursuant to the purchase agreement from the Former Parent’s Fluid Handling business divestiture, the Former Parent retained its asbestos-related contingencies and insurance coverages. However, as the Former Parent did not retain an interest in the ongoing operations of the business subject to the contingencies, asbestos-related activity was classified as part of Loss from discontinued operations, net of taxes in the Consolidated Statements of Operations of the Former Parent. The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is a standard approach used by experts and has been accepted by numerous courts. Consistent with the Former Parent, it is ESAB’s policy to record a liability for asbestos-related liability costs for the longest period of time that ESAB management can reasonably estimate. The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or a range of reasonably possible losses is estimable at the current time. Accordingly, no accrual has been recorded for any costs that may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to efforts to recover insurance from the subsidiaries’ insurers are expensed as incurred. Each subsidiary has separate insurance coverage acquired prior to Company ownership. The Company estimates the insurance assets for each subsidiary based upon the applicable policy language, expected recoveries and allocation methodologies and law pertaining to the affected subsidiary’s insurance policies. The table below summarizes the Asbestos-related claims activity since December 31, 2023 and 2022, respectively. Year Ended December 31, 2024 2023 (Number of claims) Claims unresolved, beginning of period 13,648 14,106 Claims filed (1) 5,005 4,627 Claims resolved (2) (4,895) (5,085) Claims unresolved, end of period 13,758 13,648 (In dollars) Average cost of resolved claims (3) $ 10,574 $ 9,524 (1) Claims filed include all asbestos claims for which notification has been received or a file has been opened. (2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants. (3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries. The Company’s Consolidated Balance Sheets include the amounts related to asbestos-related litigation shown in the table below. December 31, 2024 2023 (In thousands) Long-term asbestos insurance asset (1) $ 234,951 $ 221,489 Long-term asbestos insurance receivable (1) 16,961 17,868 Accrued asbestos liability (2) 40,779 32,908 Long-term asbestos liability (3) $ 253,287 $ 234,796 (1) Included in Other assets in the Consolidated Balance Sheets. (2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets. (3) Included in Other liabilities in the Consolidated Balance Sheets. Management’s analyses are based on currently known facts and assumptions. Projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded that could materially affect the Company’s financial condition, results of operations or cash flow. From time to time, other asbestos allegations related to former businesses of the Former Parent are brought against the Company. Management currently believes no loss is probable or estimable for these other matters. General Litigation The Company is involved in various pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings is expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings, and the litigation and claims described in the proceeding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Legal costs related to proceedings or claims are recorded when incurred. Other costs that management estimates may be paid related to the claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company. Off-Balance Sheet Arrangements As of December 31, 2024, the Company had $143.3 million of unconditional purchase obligations with suppliers, the majority of which is expected to be paid by December 31, 2025.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information ESAB is a focused industrial compounder. Our rich history of innovating products, workflow solutions and our business system, EBX, enables our purpose of Shaping the world we imagine TM. . Our products include fabrication technology advanced equipment, consumables, gas control equipment, robotics and digital solutions. The Company conducts its operations through two reportable segments. These segments consist of the “Americas,” which includes operations in North America and South America and “EMEA & APAC,” which includes Europe, Middle East, India, Africa and Asia Pacific. We serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified in the industrial end markets. The Company’s management considers its Chief Operating Decision Maker (“CODM”) as Shyam Kambeyanda, President, Chief Executive Officer and Director. The Company’s management and CODM evaluate the operating results of each reportable segments, including assessment of profit or loss, performance and allocation of resources, based upon Net sales and Adjusted EBITDA, which represents Net income from continuing operations excluding the impact of Income tax expense, Interest expense and other, net, Pension settlement loss (gain), Restructuring and other related charges, Separation costs, Acquisition - amortization and other related charges and Depreciation and other amortization . Segment results reflect the allocation of corporate overhead costs, which primarily consist of Selling, general and administrative expense. The Company’s segment results are included in the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Net sales (1) : Americas $ 1,176,745 $ 1,214,998 $ 1,128,306 EMEA & APAC 1,564,058 1,559,768 1,465,174 $ 2,740,803 $ 2,774,766 $ 2,593,480 Cost of sales: Americas $ 711,082 $ 760,134 $ 752,641 EMEA & APAC 992,266 998,881 955,309 $ 1,703,348 $ 1,759,015 $ 1,707,950 Allocated corporate overhead operating expense: Americas $ 64,517 $ 64,668 $ 55,328 EMEA & APAC 97,807 103,984 85,527 $ 162,324 $ 168,652 $ 140,855 Other operating expense: Americas $ 161,946 $ 165,454 $ 131,760 EMEA & APAC 184,411 180,543 176,161 $ 346,357 $ 345,997 $ 307,921 Adjusted EBITDA (2) : Americas $ 239,200 $ 224,742 $ 188,577 EMEA & APAC 289,574 276,360 248,177 $ 528,774 $ 501,102 $ 436,754 Depreciation, amortization and other impairment charges: Americas $ 31,193 $ 34,589 $ 29,281 EMEA & APAC 35,978 40,445 36,697 $ 67,171 $ 75,034 $ 65,978 Capital expenditures: Americas $ 22,648 $ 21,576 $ 18,005 EMEA & APAC 29,131 26,602 22,238 $ 51,779 $ 48,178 $ 40,243 (1) For the years ended December 31, 2024, 2023 and 2022, the total Net sales originating from the United States were $595.6 million, $619.1 million and $583.0 million, respectively. (2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA: Year Ended December 31, 2024 2023 2022 (In thousands) Net income from continuing operations $ 293,057 $ 223,365 $ 231,081 Income tax expense 77,348 95,727 69,170 Interest expense and other, net 64,890 85,074 37,950 Pension settlement loss (gain) 12,155 — (9,136) Restructuring and other related charges (1) 10,227 24,110 23,096 Separation costs (2) — — 15,545 Acquisition - amortization and other related charges (3) 34,479 36,851 34,196 Depreciation and other amortization 36,618 35,975 34,852 Adjusted EBITDA $ 528,774 $ 501,102 $ 436,754 (1) I ncludes severance and other termination benefits, including outplacement services, as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines . (2) I ncludes non-recurrin g charges and employee costs related to the planning and execution of t he Separation within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations. (3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses. December 31, 2024 2023 (In thousands) Investments in equity method investees: Americas $ — $ — EMEA & APAC 28,885 30,633 $ 28,885 $ 30,633 Total assets: Americas $ 1,796,167 $ 1,671,634 EMEA & APAC 2,237,808 2,156,995 $ 4,033,975 $ 3,828,629 December 31, 2024 2023 (In thousands) Property, plant and equipment, net (1) : United States $ 73,036 $ 68,398 Czech Republic 55,554 60,948 India 31,506 31,258 Mexico 20,495 23,922 Poland 17,227 14,661 Russia 12,225 15,550 Other foreign countries 88,304 79,568 $ 298,347 $ 294,305 (1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Related Party Agreements On April 4, 2022, in connection with the Separation, the Company entered into several agreements with Enovis that govern the Separation and provide a framework for the relationship between the parties going forward including a separation and distribution agreement, transition services agreement, tax matters agreement, employee matters agreements, stockholders and registration rights agreement, intellectual property matters agreement and license agreement for EBX. Separation and Distribution Agreement The Company entered into a separation and distribution agreement (the “Separation Agreement”) with Enovis immediately prior to the distribution of the Company’s common stock to Enovis stockholders. The Separation Agreement sets forth the Company’s agreements with Enovis regarding the principal actions to be taken in connection with the Separation. The Separation Agreement contains provisions that, among other things, relate to (i) assets, liabilities and contracts to be transferred, assumed and assigned to each of ESAB and Enovis as part of the Separation, (ii) cash distribution made to Enovis in partial consideration of the transfer of ESAB Assets to the Company in connection with the Separation and (iii) cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of ESAB’s business with ESAB and financial responsibility for the obligations and liabilities of Enovis’s remaining business with Enovis. Transition Services Agreement The transition services agreement sets forth the terms and conditions pursuant to which the Company and its subsidiaries and Enovis and its subsidiaries will provide to each other various services. As of the year ended December 31, 2024, the related obligations have been closed out. Tax Matters Agreement The tax matters agreement governs the Company’s and Enovis’s respective rights, responsibilities and obligations after the Separation with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and certain other matters regarding taxes. Employee Matters Agreement The employee matters agreement sets forth, among other things, the allocation of assets, liabilities and responsibilities relating to employee compensation and benefit plans and programs and other related matters in connection with the Separation, including the treatment of outstanding equity and other incentive awards and certain retirement and welfare benefit obligations. Stockholders and Registration Rights Agreement The stockholders and registration rights agreement sets forth the rights of the stockholders when requiring the Company to facilitate the resale of shares. Intellectual Property Matters Agreement The intellectual property matters agreement sets forth the terms and conditions pursuant to which Enovis and the Company have mutually granted certain personal, generally irrevocable, non-exclusive, worldwide and royalty-free rights to use certain intellectual property. The Company and Enovis are able to sublicense their rights in connection with activities relating to their businesses, but not for independent use by third parties. EBX License Agreement The EBX license agreement sets forth the terms and conditions pursuant to which Enovis has granted a royalty-free, non-exclusive, worldwide and nontransferable license to the Company to use EBX, solely in support of its businesses. The Company will be able to sublicense such license solely to direct and indirect wholly-owned subsidiaries. In addition, under the EBX license agreement, Enovis and the Company each license to each other improvements made by such party to EBX during the first two years of the term of the EBX license agreement. Allocated Expenses Prior to the Separation, the Company operated as part of the Former Parent and not as a stand-alone company. Accordingly, the Former Parent allocated certain shared costs to the Company that are reflected as expenses in these financial statements. These amounts included, but were not limited to, items such as general management and executive oversight, compliance, human resources, procurement and legal functions and financial management, including public company reporting, consolidated tax filings and tax planning. Management considered the allocation methodologies used by the Former Parent to be reasonable and to appropriately reflect the related expenses attributable to the Company for purposes of the three months ended April 1, 2022 combined financial statements; however, the expenses reflected in these financial statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company had operated as a separate stand-alone entity. The Company had no stock-based compensation plans prior to the Separation; however, certain employees of the Company participated in the Former Parent’s stock-based compensation plans, which provided for the grants of stock options and RSUs among other types of awards. The expense associated with the Company's employees who participated in the plans of the Former Parent was allocated to the Company in the accompanying Consolidated and Combined Statements of Operations through the date of Separation. The Company’s allocated expenses from the Former Parent were $6.0 million for the three months ended April 1, 2022, and is included in the Selling, general and administrative expense in the Consolidated and Combined Statements of Operations. Following the Separation, the Company independently incurs expenses as a stand-alone company. Refer to Note 14, “Benefit Plans,” for allocations of net periodic benefit associated with a Former Parent sponsored benefit plan.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The dividend of $4.9 million included in Accrued liabilities in the Consolidated Balance Sheets at December 31, 2024 was paid on January 17, 2025, to stockholders of record as of December 31, 2024. On February 18, 2025, the Company entered into an agreement to acquire Bavaria Schweisstechnik, a European provider of submerged-arc welding applications, for approximately €60 million of cash consideration. This acquisition is expected to be completed during 2025, subject to the receipt of applicable regulatory approvals and customary closing conditions.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	Balance at Charged to Cost and (1) Write-Offs Write-Downs Deductions and Other (2) Foreign Balance at (Dollars in thousands) Year Ended December 31, 2024: Allowance for credit losses $ 25,477 $ 2,248 $ (2,423) $ (1,452) $ 23,850 Valuation allowance for deferred tax assets 79,355 (761) (12,478) (1,109) 65,007 Year Ended December 31, 2023: Allowance for credit losses $ 23,471 $ 3,902 $ (2,289) $ 393 $ 25,477 Valuation allowance for deferred tax assets 88,202 (12,283) — 3,426 79,355 Year Ended December 31, 2022: Allowance for credit losses $ 23,912 $ 4,526 $ (4,978) $ 11 $ 23,471 Valuation allowance for deferred tax assets (2) 15,465 4,503 68,876 (642) 88,202 (1) Amounts charged to expense are net of recoveries for the respective period. (2) As of December 31, 2022, valuation allowance for deferred tax assets “Other” of $68.9 million is primarily due to valuation allowance transferred from Former Parent.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 264,842	$ 205,285

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Dec. 31, 2024 shares	Dec. 31, 2024 shares
Trading Arrangements, by Individual
Name	Mr. Olivier Biebuyck
Title	President
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Adoption Date	March 13, 2025
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Expiration Date	December 31, 2025
Arrangement Duration	293 days
Aggregate Available	16,266	16,266
Mr. Christopher M. Hix [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On December 13, 2024, Mr. Olivier Biebuyck, President, Fabrication Technology of the Company, adopted a trading plan intended to satisfy Rule 10b5-1(c) to sell up to 16,266 shares of Company common stock between March 13, 2025 and December 31, 2025, subject to certain conditions, all of which shares are to be acquired upon the exercise of employee stock options.

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Cybersecurity related risks are integrated into our overall enterprise risk management (“ERM”) process. As a result, risks posed by cybersecurity threats are among the risks that the Company’s ERM process evaluates and assesses at least annually. The results of this risk assessment, including cybersecurity, are presented to the Board of Directors annually. The cybersecurity team implements, monitors and maintains controls that are aligned with the guidance defined by the National Institute of Standards and Technology (“NIST”) CyberSecurity Framework. These controls are designed to protect the confidentiality, availability and integrity of information systems. Our cybersecurity processes include automated tools and technical safeguards managed and monitored by our cybersecurity team. We view cybersecurity as a responsibility shared by all of our associates. As an organization committed to continuous improvement, we periodically conduct incident response tabletop exercises with key members of our leadership team, including our Chief Executive Officer, perform internal and external assessments and engage consultants to help assess the design and effectiveness of our program. In addition, we expect all of our associates as well as our third-party vendors to help protect against cybersecurity risks, and we conduct periodic awareness campaigns, emerging threats communications and specific trainings. We have adopted a Global Cybersecurity Incident Response Procedure that applies in the event of a cybersecurity threat or incident. These procedures include an incident response playbook that outlines the steps to be addressed in the event of a cybersecurity incident, from incident detection to mitigation, recovery and notification within the Company and to the Audit Committee and/or Board of Directors, as specified. We also rely on information technology and third-party vendors to support our operations, including our secure processing of personal, confidential, sensitive, proprietary and other types of information. We employ systems and processes designed to oversee, identify and reduce the potential impact of a security incident at a third-party vendor, service provider or customer or otherwise implicating the third-party technology and systems we use. Despite ongoing efforts to continuously improve our holistic ability to protect against cyber incidents, we may not be able to protect all information systems, and such incidents may lead to reputational harm, disruption of our business operations, revenue and client loss, legal actions, or statutory penalties, among other consequences. Due to evolving cybersecurity threats, it has and will continue to be difficult to prevent, detect, mitigate and remediate cybersecurity incidents. While we are not aware of any material cybersecurity threats or incidents that have had or are reasonably likely to materially affect us, including those having a long-term impact on our business strategy, results of operations or financial condition, there can be no guarantee that we will not be the subject of future successful attacks, threats or incidents. For additional information on the cybersecurity risks faced by our Company, refer to Item 1A. “Risk Factors—Risks Related to Our Business— Our electronic information systems have been and could in the future be, subject to service interruptions, data corruption, cyber-based attacks and network security breaches. Significant disruptions in, or breaches in security of, our electronic information systems or data can adversely affect our business and financial statements .”
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Cybersecurity related risks are integrated into our overall enterprise risk management (“ERM”) process. As a result, risks posed by cybersecurity threats are among the risks that the Company’s ERM process evaluates and assesses at least annually. The results of this risk assessment, including cybersecurity, are presented to the Board of Directors annually
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	The Board maintains responsibility for oversight of risks that may affect the Company. Our Board has delegated the primary responsibility to oversee cybersecurity matters to the Audit Committee. The Audit Committee reviews the Company’s policies with respect to risk assessment and enterprise risk management, including with respect to cybersecurity risks. Certain members of our Audit Committee have experience with respect to cybersecurity risk management.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Board maintains responsibility for oversight of risks that may affect the Company. Our Board has delegated the primary responsibility to oversee cybersecurity matters to the Audit Committee. The Audit Committee reviews the Company’s policies with respect to risk assessment and enterprise risk management, including with respect to cybersecurity risks. Certain members of our Audit Committee have experience with respect to cybersecurity risk management. The Audit Committee regularly reviews the measures implemented by the Company to identify and mitigate data protection and cybersecurity risks. As part of such reviews, the Audit Committee receives reports and presentations from members of the Company’s management team responsible for overseeing the Company’s cybersecurity risk program, including our Chief Information Officer (“CIO”). These reports and updates may address a wide range of topics, including recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends and information security considerations arising with respect to the Company’s peers and third parties. The Audit Committee periodically reports to the Board on data protection and cybersecurity matters. We also have protocols by which certain cybersecurity incidents are escalated within the Company and, in certain circumstances, reported to the Board and/or Audit Committee in a timely manner.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Audit Committee regularly reviews the measures implemented by the Company to identify and mitigate data protection and cybersecurity risks. As part of such reviews, the Audit Committee receives reports and presentations from members of the Company’s management team responsible for overseeing the Company’s cybersecurity risk program, including our Chief Information Officer (“CIO”). These reports and updates may address a wide range of topics, including recent developments, evolving standards, vulnerability assessments, third-party and independent reviews, the threat environment, technological trends and information security considerations arising with respect to the Company’s peers and third parties. The Audit Committee periodically reports to the Board on data protection and cybersecurity matters. We also have protocols by which certain cybersecurity incidents are escalated within the Company and, in certain circumstances, reported to the Board and/or Audit Committee in a timely manner. At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents. In conjunction with management, the CIO regularly reviews risk management measures to identify and mitigate data protection and cybersecurity risks. Key performance indicators, emerging threats, current trends and notable detections are reported to members of the Company’s senior leadership team. The global cybersecurity team also works closely with our legal team to address legal, regulatory and contractual requirements.
Cybersecurity Risk Role of Management [Text Block]	At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents. In conjunction with management, the CIO regularly reviews risk management measures to identify and mitigate data protection and cybersecurity risks. Key performance indicators, emerging threats, current trends and notable detections are reported to members of the Company’s senior leadership team. The global cybersecurity team also works closely with our legal team to address legal, regulatory and contractual requirements.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	At the management level, our CIO is responsible for overseeing and implementing a cybersecurity strategy aligned with the Company’s goals and needs. Our CIO has extensive experience with respect to cybersecurity matters as a result of over 20 years of relevant work experience. Our cybersecurity function is supported by highly trained cybersecurity personnel with substantial industry experience as well as our network of specialized consulting partners, regional IT leaders and our global IT infrastructure team. Our CIO receives ongoing updates from such individuals regarding the prevention, detection, mitigation and remediation of cybersecurity incidents.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	In conjunction with management, the CIO regularly reviews risk management measures to identify and mitigate data protection and cybersecurity risks. Key performance indicators, emerging threats, current trends and notable detections are reported to members of the Company’s senior leadership team. The global cybersecurity team also works closely with our legal team to address legal, regulatory and contractual requirements.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Fiscal Period	The Company’s fiscal year ends December 31. The Company’s first three quarters end on the last business day of the 13th week after the end of the prior quarter.
Separation from Enovis and Principles of Consolidation	Separation from Enovis On April 4, 2022 (the “Distribution Date”), Colfax Corporation (“Colfax,” “Enovis” or the “Former Parent”) completed the spin-off of Colfax’s Fabrication Technology business and certain other corporate entities, through a tax-free, pro rata distribution (the “Distribution”) of 90% of the outstanding common stock of ESAB to Colfax stockholders (the spin-off and related distribution, collectively, the “Separation”). To effect the Separation, each Colfax stockholder of record as of close of business on March 23, 2022 received one share of ESAB common stock for every three shares of Colfax common stock held on the record date. As of the year ended December 31, 2022, Enovis no longer owned any of the Company’s outstanding common stock. In connection with the Separation, on April 4, 2022, ESAB and Enovis entered into a separation and distribution agreement as well as various other related agreements (collectively the “Separation Agreements”) that govern the Separation and the relationships between the parties going forward, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement and license agreement for EBX. Refer to Note 21, “Related Party Transactions” for further details. Principles of Consolidation The Company’s Consolidated and Combined Financial Statements include all majority-owned subsidiaries over which the Company exercises control and, when applicable, entities or joint ventures for which the Company has a controlling financial interest or is the primary beneficiary. When protective rights, substantive rights or other factors exist, further analysis is performed to determine whether or not there is a controlling financial interest. The Consolidated and Combined Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest. All significant intercompany accounts and transactions have been eliminated.
Basis of Presentation	Basis of Presentation The accompanying Consolidated and Combined Financial Statements present the Company’s historical financial position, results of operations, changes in equity and cash flows in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) in conformity with generally accepted accounting principles in the United States (“GAAP”). The Consolidated and Combined Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Intercompany transactions and accounts are eliminated in consolidation. The combined financial statements for the period prior to the Separation were derived from Enovis’s consolidated financial statements and accounting records and prepared in accordance with GAAP for the preparation of carved-out combined financial statements. Through the date of the Separation, all revenues and costs as well as assets and liabilities directly associated with ESAB have been included in the combined financial statements. Prior to the Separation, the combined financial statements also included allocations of certain general, administrative, sales and marketing expenses from Enovis’s corporate office and from other Enovis businesses to the Company and allocations of related assets, liabilities and the Former Parent’s investment, as applicable. The allocations were determined on a reasonable basis, however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had the Company been an entity that operated independently of Enovis during the applicable periods. Related party allocations prior to the Separation, including the method for such allocation, are discussed further in Note 21, “Related Party Transactions.” Transactions with the Former Parent are reflected in the accompanying Consolidated and Combined Statements of Equity as “Net Transfers from Former Parent, including Separation Adjustments” for the year ended December 31, 2022. For the periods subsequent to April 4, 2022, the financial statements are presented on a consolidated basis and no longer include any allocations of expenses from Enovis, as the Company became a standalone public company.
Use of Estimates	Use of Estimates The Company makes certain estimates and assumptions in preparing its Consolidated and Combined Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Consolidated and Combined Financial Statements and the reported amounts of revenues and expenses for the period presented. Actual results may differ from those estimates.
Equity Method Investments	Equity Method Investments
Revenue Recognition	Revenue Recognition The Company recognizes revenue when control of promised goods or services is transferred to the customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled in exchange for transferring the goods or services. The Company provides a variety of products and services to its customers. Most of the Company’s contracts consist of a single, distinct performance obligation or promise to transfer goods or services to a customer. For contracts that include multiple performance obligations, we allocate the total transaction price to each performance obligation using our best estimate of the stand-alone selling price of each identified performance obligation. A significant majority of our revenue relates to the shipment of off-the-shelf products that is recognized when control is transferred to the customer. On a limited basis, we have agreements with customers that have multiple performance obligations. In determining whether there are multiple performance obligations, we first assess the goods or services promised in the customer arrangement and then consider the guidance in ASC 606, Revenue from Contracts with Customers , to evaluate whether goods and services are capable of being distinct and are considered distinct within the customer arrangement. To determine whether promised goods or services are separately identifiable (i.e., whether a promise to transfer a good or service is distinct in the context of the contract), we evaluate whether the contract is to deliver (1) multiple promised goods or services or (2) a combined item that comprises the individual goods or services promised in the contract. Substantially all revenue involving development and application engineering projects consists of a single performance obligation and is recognized at a point in time. As mentioned above, a majority of revenue recognized by the Company relates to contracts with customers for standard or off-the-shelf products. As control typically transfers to the customer upon shipment of the product in these circumstances, revenue is generally recognized at that point in time. Revenue recognition and billing typically occur simultaneously for contracts recognized at a point in time. Therefore, we do not have material revenues in excess of customer billings or billings to customers in excess of recognized revenues. Refer to Note 6, “Revenue” and Note 13, “Accrued and Other Liabilities” for additional information on the Company’s contract liability balances and related information. The period of benefit for the Company’s incremental costs of obtaining a contract generally have less than a one-year duration; therefore, the Company applies the practical expedient available and expenses costs to obtain a contract when incurred. Taxes Collected from Customers and Remitted to Governmental Authorities The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis within Net sales in the Consolidated and Combined Statements of Operations and are recorded as a component of Accrued liabilities in the Consolidated Balance Sheets until remitted to the respective taxing authority.
Research and Development Expense	Research and Development Expense Research and development costs of $39.2 million , $38.8 million and $36.0 million for the years ended December 31, 2024 , 2023 and 2022
Cash and Cash Equivalents	Cash and Cash Equivalents
Trade Receivables	Trade Receivables
Inventories	Inventories Inventories are valued at the lower of cost or net realizable value. Fixed manufacturing overhead costs are allocated to inventory based on normal production capacity and abnormal manufacturing activities are recognized as period costs. As of December 31, 2023 , cost for a substantial portion of United States inventories was determined using the last-in, first-out (“LIFO”) method. The value of inventory stated on a LIFO basis as of December 31, 2023 was $107.8 million and t he valuation of LIFO inventories was made at the end of the year based on inventory levels and costs at that time. Cost of other inventories is determined by costing methods that approximate a first-in, first-out (“FIFO”) method. During the fourth quarter of 2024 , the Company changed its inventory costing methodology from the previously disclosed LIFO method to the FIFO method for a portion of its inventory, as of the year ended December 31, 2024 all inventory is valued under FIFO. The Company performed this change because it believes FIFO is preferable given it provides a more consistent method for valuing inventory across the Company, better matches costs with revenues, improves comparability with peers and better reflects the current value of inventory at the balance sheet date. The LIFO expense for the years ended December 31, 2023 and 2022 were $2.1 million and $3.3 million, respectively which are not considered material to the Company’s financial statements. The Company recorded the pre-tax cumulative benefit related to this change in accounting principle of $4.3 million as a reduction of Cost of sales for the year ended December 31, 2024. Since these amounts are immaterial to all periods presented, the impact of this change was not retrospectively reflected in prior years. For further information, refer to Note 11, “Inventories, Net.” Reserves are maintained for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and the net realizable value based upon assumptions about future demand and market conditions. The reserve for excess and obsolete inventory was $41.2 million and $47.6 million as of December 31, 2024 and 2023, respectively.
Property, Plant and Equipment	Property, Plant and Equipment
Impairment of Goodwill and Indefinite-Lived Intangible Assets	Impairment of Goodwill and Indefinite-Lived Intangible Assets Goodwill represents the costs in excess of the fair value of net assets acquired through acquisitions by the Company. The Company evaluates the recoverability of Goodwill and indefinite-lived intangible assets annually or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. The annual impairment test date elected by the Company is the first day of its fourth quarter. Goodwill and indefinite-lived intangible assets are considered to be impaired when the carrying value of a reporting unit or asset exceeds its fair value. As of the annual impairment test date, the Company had three reporting units: Americas, EMEA & APAC and Gas Control Equipment (“GCE”). In the evaluation of goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting entity is less than its carrying value. If the Company determines that it is more likely than not for a reporting unit’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not for a reporting unit’s fair value to be less than its carrying value, a calculation of the reporting unit’s fair value is performed and compared to the carrying value of that reporting unit. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying value of a reporting unit exceeds its fair value, goodwill of that reporting unit is impaired and an impairment loss is recorded equal to the excess of the reporting unit’s carrying value over its fair value. When a quantitative impairment test is needed, the Company measures fair value of reporting units based on a present value of future discounted cash flows. The discounted cash flow models indicate the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flow models include the weighted-average cost of capital, net sales and profitability of our business. For the years ended December 31, 2024, 2023 and 2022, a qualitative Goodwill impairment assessment was performed for the three reporting units, all of which indicated no impairment existed and therefore, no impairment charges were recorded for the respective periods. No material events that would represent impairment indicators have occurred subsequent to the performance of the 2024 annual impairment test. In the evaluation of indefinite-lived intangible assets for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived intangible asset is less than its carrying value. If the Company determines that it is more likely than not for the indefinite-lived intangible asset’s fair value to be greater than its carrying value, a calculation of the fair value is not performed. If the Company determines that it is more likely than not that the indefinite-lived intangible asset’s fair value is less than its carrying value, a fair value calculation is performed and compared to the carrying value of the asset. In certain instances, the Company may elect to forgo the qualitative assessment and proceed directly to the quantitative impairment test. If the carrying amount of the indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company measures the fair value of its indefinite-lived intangible assets using the “relief from royalty” method. Significant estimates in this approach include projected revenues and royalty and discount rates for each trade name evaluated. At the impairment testing date, the first day of the fourth quarter, quantitative impairment tests were performed for all the indefinite-lived trade name brands for the years ended December 31, 2024, 2023 and 2022, all of which indicated no impairment existed.
Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets	Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets Definite-lived intangible assets primarily represent acquired trade names, customer relationships, acquired technology and software license agreements. The Company uses accelerated and straight-line methods of amortization with lives ranging from five The Company assesses its long-lived assets and definite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss equal to the difference between the carrying amount of the asset and its fair value would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The Company determined that no significant impairment indicators were evident during the years ended December 31, 2024, 2023 and 2022.
Derivatives	Derivatives The Company uses derivative instruments to manage exposures to interest rates and net investment exposures. The Company does not enter into derivatives for trading or speculative purposes. All derivatives are recognized at fair value on the Company’s Consolidated Balance Sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the derivative and whether it is designated and qualifies for hedge accounting. The Company formally documents the relationship of the hedge with the hedged item as well as the risk-management strategy for all designated hedges. Both at inception and on an ongoing basis, the hedging instrument is assessed as to its effectiveness, when applicable. If and when a derivative is determined not to be highly effective as a hedge, the underlying hedged transaction is no longer likely to occur, or the derivative is terminated, hedge accounting is discontinued. The Company is subject to the credit risk of the counterparties to derivative instruments. Counterparties include a number of major banks and financial institutions. The Company manages individual counterparty exposure by monitoring the credit rating of the counterparty and the size of financial commitments and exposures between the Company and the counterparty. Certain interest rate swap agreements are qualified and designated as cash flow hedges. The effective portion of the fair value unrealized gain or loss on cash flow hedges are reported as a component of Accumulated other comprehensive loss ("AOCL") with offsetting amounts recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract. The gain or loss on the derivative instrument due to the change in fair value is reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. If a derivative is deemed to be ineffective, the change in fair value of the derivative is recognized directly in earnings. Certain cross-currency swap agreements are designated and qualify as a net investment hedge. The changes in the fair value of these instruments are recorded in AOCL in equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in AOCL. Offsetting amounts are recorded in the Company’s Consolidated Balance Sheets depending on the position and the duration of the contract. The Company has certain foreign currency contracts that are not designated as hedges. These derivatives are held as offsets to certain balance sheet exposures. The gains or losses on these contracts are recognized in Interest expense and other, net, in the Company’s Consolidated and Combined Statement of Operations.
Warranty Costs	Warranty Costs Estimated expenses related to product warranties are accrued as the revenue is recognized on products sold to customers and included in Cost of sales in the Consolidated and Combined Statements of Operations. Estimates are established using historical information as to the nature, frequency and average costs of warranty claims.
Income Taxes	Income Taxes Prior to the Separation, the Company’s domestic and foreign operating results were included in the income tax returns of Enovis. The Company accounted for income taxes under the separate return method. Under this approach, the Company determined its deferred tax assets and liabilities and related tax expense as if it were filing separate tax returns. The Company accounts for income taxes under ASC 740 , Income Taxes (“ASC 740”), which requires recognition of deferred income tax assets and liabilities reflecting the tax consequences attributable to differences between the carrying amounts of existing assets and liabilities in the Consolidated and Combined Financial Statements and their respective tax basis. Deferred income tax assets and liabilities are measured using enacted tax rates expected to be applied to taxable income in the years in which those temporary differences are expected to be recovered or settled. Deferred income tax assets and liabilities are reported in Other assets and Other liabilities in the Consolidated Balance Sheets, respectively. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in Income tax expense in the period that includes the enactment date. Global Intangible Low-Taxed Income is accounted for as a current tax expense in the year the tax is incurred. Valuation allowances are recorded if it is more likely than not that some portion of the deferred income tax assets will not be realized. In evaluating the need for a valuation allowance, the Company considers various factors, including the expected level of future taxable income and available tax planning strategies. Any changes in judgment about the valuation allowance are recorded through Income tax expense and are based on changes in facts and circumstances regarding realizability of deferred tax assets. The Company must presume that an income tax position taken in a tax return will be examined by the relevant tax authority and determine whether it is more likely than not that the tax position will be sustained upon examination based upon the technical merits of the position. An income tax position that meets the more-likely-than-not recognition threshold is measured to determine the amount of benefit to recognize in the financial statements. The Company establishes a liability for unrecognized income tax benefits for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority to the extent such tax positions reduce the Company’s income tax liability. The Company recognizes interest and penalties related to unrecognized income tax benefits in Income tax expense in the Consolidated and Combined Statements of Operations.
Interest expense (income) and Other, Net	Interest Expense and Other, Net Interest expense and other, net is comprised of interest-bearing deposits of certain foreign subsidiaries, interest costs for the Company’s debt, amortization of debt issuance costs and interest expense of derivatives designated in hedging relationships. In addition, it is comprised of: • other non-operating expense (income) items, including certain pension-related activities, • foreign exchange exposure on cash and intercompany positions and interest income or expense on foreign currency contracts not designated in hedging relationships and • Argentina highly inflationary accounting transaction exchange loss on cash and cash equivalent remeasured into the Brazilian real - the direct parent’s currency. See “Foreign Currency Exchange Gains and Losses” and “Argentina Highly Inflationary Accounting” policies below for additional information.
Foreign Currency Exchange Gains and Losses	Foreign Currency Exchange Gains and Losses The Company’s Consolidated and Combined Financial Statements are presented in U.S. Dollars. The functional currencies of the Company’s operating subsidiaries are generally the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. The amounts recorded in each year in Foreign currency translation in Equity are net of income taxes to the extent the underlying equity balances in the entities are not deemed to be permanently reinvested. Revenues and expenses are translated at average rates of exchange in effect during the year. Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the Consolidated Balance Sheets are recognized in Selling, general and administrative expense or Interest expense and other, net in the Consolidated and Combined Statements of Operations for that period.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements The Company assesses the adoption impacts of recently issued accounting pronouncements on the Company’s Consolidated and Combined Financial Statements as well as material updates to previous assessments. Accounting Guidance Implemented in 2024 In November 2023, the Financial Accounting Standards Board (the “FASB”) issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances segment reporting by expanding the breadth and frequency of disclosures through incremental information about significant segment expenses. The guidance also requires disclosure of the Chief Operating Decision Maker’s (the “CODM”) position and detail of how the CODM uses financial reporting to assess the segment’s performance. The new guidance is effective for fiscal years beginning after December 15, 2023 and for interim periods beginning after December 15, 2024. The Company has adopted this guidance for the year ending December 31, 2024, and as discussed above, the primary impact is increased disclosure of certain financial information by segment. Refer to Note 20. “Segment Information” for further information on the impact on the Company’s disclosures. Recently Issued Accounting Guidance Not Yet Adopted In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures , which expands disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. The ASU is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the effect the adoption of the ASU may have on its disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location	The table below shows the effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations. Year Ended December 31, Derivative type (Gain) recognized in the Consolidated and Combined Statements of Operations 2024 2023 Cross currency-swap agreements Interest expense and other, net $ (4,687) $ (4,779)
Schedule of Net Foreign Transaction Gains and Losses	The following table summarizes the Company’s net foreign transaction gains and losses included within the Consolidated and Combined Statements of Operations. Year Ended December 31, 2024 2023 2022 (In thousands) (1) Selling, general and administrative expense $ 7,136 $ 11,389 $ 2,597 Interest expense and other, net (158) 1,719 109 Foreign currency transaction loss, net (2) $ 6,978 $ 13,108 $ 2,706 (1) This table excludes the foreign currency exchange impacts of applying highly inflationary accounting for the Company’s Argentina operations, as described in the “Argentina Highly Inflationary Accounting” paragraph below. (2) During 2023, the weakening of the Ruble and certain South American currencies drove the increase in the loss on transactions denominated in foreign currencies.

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The Company disaggregates its revenue into the product groups included in the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Equipment $ 893,313 $ 854,949 $ 740,824 Consumables 1,847,490 1,919,817 1,852,656 Total $ 2,740,803 $ 2,774,766 $ 2,593,480
Schedule of Accounts Receivable, Allowance for Credit Loss	the activity in the Company’s Allowance for credit losses included within Trade receivables in the Consolidated Balance Sheets. Year Ended December 31, 2024 Balance at Beginning of Period Charged to Expense, net Write-Offs and Deductions Foreign Currency Translation Balance at (In thousands) Allowance for credit losses $ 25,477 $ 2,248 $ (2,423) $ (1,452) $ 23,850

Earnings per Share from Conti_2

Earnings per Share from Continuing Operations (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share from Continuing Operations	The table below summarizes how the Company allocates earnings to participating securities and computed earnings per share using the two-class method. Year Ended December 31, 2024 2023 2022 (In thousands, except share and per share data) Computation of earnings per share from continuing operations – basic: Income from continuing operations attributable to ESAB Corporation (1) $ 287,151 $ 217,626 $ 226,815 Less: distributed and undistributed earnings allocated to nonvested shares (1,370) (1,555) (1,600) Income from continuing operations attributable to common stockholders $ 285,781 $ 216,071 $ 225,215 Weighted-average shares of Common stock outstanding – basic 60,427,743 60,233,623 60,054,930 Income per share from continuing operations – basic $ 4.73 $ 3.59 $ 3.75 Computation of earnings (loss) per share from continuing operations – diluted: Income from continuing operations attributable to common stockholders $ 285,781 $ 216,071 $ 225,215 Weighted-average shares of Common stock outstanding – basic 60,427,743 60,233,623 60,054,930 Net effect of potentially dilutive securities (2) 674,320 422,123 98,129 Weighted-average shares of Common stock outstanding – dilution 61,102,063 60,655,746 60,153,059 Net income per share from continuing operations – diluted $ 4.68 $ 3.56 $ 3.74 (1) Net income from continuing operations attributable to ESAB Corporation for the respective periods is calculated using Net income from continuing operations, less Income attributable to noncontrolling interest, net of taxes, o f $5.9 million, $5.7 million and $4.3 million for the years ended December 31, 2024, 2023 and 2022, respectively. (2) Potentially dilutive securities include stock options, performance-based restricted stock units and non performance-based restricted stock units.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Income from continuing operations before income taxes and Income tax expense consisted of the following per the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Income from continuing operations before income taxes: Domestic operations $ 50,212 $ 37,364 $ (19,234) Foreign operations 320,193 281,728 319,485 $ 370,405 $ 319,092 $ 300,251 Income tax expense: Current: Federal $ 15,717 $ 18,034 $ 8,928 State 2,635 3,760 2,451 Foreign 58,761 99,036 77,728 77,113 120,830 89,107 Deferred: Federal 2,489 (11,897) (7,501) State (126) (1,341) 358 Foreign (2,128) (11,865) (12,794) 235 (25,103) (19,937) $ 77,348 $ 95,727 $ 69,170
Schedule of Components of Income Tax Expense (Benefit)	Income from continuing operations before income taxes and Income tax expense consisted of the following per the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Income from continuing operations before income taxes: Domestic operations $ 50,212 $ 37,364 $ (19,234) Foreign operations 320,193 281,728 319,485 $ 370,405 $ 319,092 $ 300,251 Income tax expense: Current: Federal $ 15,717 $ 18,034 $ 8,928 State 2,635 3,760 2,451 Foreign 58,761 99,036 77,728 77,113 120,830 89,107 Deferred: Federal 2,489 (11,897) (7,501) State (126) (1,341) 358 Foreign (2,128) (11,865) (12,794) 235 (25,103) (19,937) $ 77,348 $ 95,727 $ 69,170
Schedule of Effective Income Tax Rate Reconciliation	The Company’s Income tax expense differs from the amount that would be computed by applying the United States federal statutory rate as follows in the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Taxes calculated at the United States federal statutory rate $ 77,785 $ 67,010 $ 63,053 State taxes 1,956 1,630 2,809 Effect of tax rates on international operations 1,823 1,548 (9,010) Changes in tax reserves (4,206) 10,753 (350) Research and development tax credits (980) (714) (542) Effect of United States taxation on international operations 5,239 1,527 310 Permanent differences, net (4,061) 10,077 7,209 Provision to return (8,350) 703 (7,055) Withholding taxes 6,634 11,172 12,133 Capital gain — — (3,655) Valuation Allowance (761) (12,308) 4,503 Other 2,269 4,329 (235) Income tax expense $ 77,348 $ 95,727 $ 69,170
Schedule of Deferred Tax Assets and Liabilities	The table below shows the temporary differences that gave rise to the significant components of deferred tax assets and liabilities. December 31, 2024 2023 (In thousands) Deferred tax assets: Post-retirement benefit obligation $ 1,229 $ 1,350 Expenses currently not deductible 59,518 52,526 Net operating loss carryforward 86,716 107,395 Tax credit carryforward 5,137 4,581 Depreciation and amortization 4,286 7,404 Inventory 10,795 12,238 Capitalized R&D costs 20,556 18,178 Leases 21,490 23,987 Other — 2,867 Valuation allowance (65,007) (79,355) Deferred tax assets, net $ 144,720 $ 151,171 Deferred tax liabilities: Depreciation and amortization $ (125,227) $ (120,055) Leases (22,084) (23,987) Outside basis differences and other (87,434) (79,985) Total deferred tax liabilities (234,745) (224,027) Total deferred tax liabilities, net $ (90,025) $ (72,856) Deferred tax assets and liabilities have been classified as noncurrent and are included in Other assets and Other liabilities in the accompanying Consolidated Balance Sheets on a net jurisdictional basis as broken out in the table below. December 31, 2024 2023 (In thousands) Other assets $ 44,816 $ 46,602 Other liabilities (134,841) (119,458) Deferred tax liability, net $ (90,025) $ (72,856)
Schedule of Unrecognized Tax Benefits Roll Forward	reconciliation of the beginning and ending amount of gross unrecognized tax benefits (inclusive of associated interest and penalties). (In thousands) Balance, January 1, 2022 $ 37,681 Addition for tax positions taken in prior periods 1,971 Addition for tax positions taken in the current period 1,171 Reductions related to settlements with taxing authorities (922) Reductions resulting from a lapse of applicable statute of limitations (2,801) Other, including the impact of foreign currency translation and United States tax rate changes (16,897) Balance, December 31, 2022 20,203 Addition for tax positions taken in prior periods 13,514 Reductions related to settlements with taxing authorities (4,160) Transfer from Former Parent, impact of foreign currency translation and other (473) Other, including the impact of foreign currency translation and United States tax rate changes 1,787 Balance, December 31, 2023 30,871 Addition for tax positions taken in prior periods 6,436 Reductions for tax positions taken in prior periods (7,825) Reductions related to settlements with taxing authorities (9,255) Reductions resulting from a lapse of applicable statute of limitations (51) Other, including the impact of foreign currency translation (3,092) Balance, December 31, 2024 $ 17,084

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes Goodwill activity by segment for the years ended December 31, 2024 and 2023. Americas EMEA & APAC Total (In thousands) Balance, January 1, 2023 $ 585,845 $ 943,922 $ 1,529,767 Goodwill attributable to acquisition 1,664 13,912 15,576 Impact of foreign currency translation 2,366 40,622 42,988 Balance, December 31, 2023 589,875 998,456 1,588,331 Goodwill attributable to acquisitions 44,505 46,691 91,196 Impact of foreign currency translation (4,675) (22,859) (27,534) Balance, December 31, 2024 $ 629,705 $ 1,022,288 $ 1,651,993
Schedule of Indefinite-Lived Intangible Assets	The following table summarizes the Company’s Intangible assets, excluding Goodwill. December 31, 2024 2023 Gross Accumulated Gross Accumulated (In thousands) Indefinite-Lived Intangible Assets: Trade names $ 173,912 $ — $ 185,301 $ — Definite-Lived Intangible Assets: Customer relationships 506,226 (248,920) 496,483 (231,848) Technology 71,912 (55,539) 73,288 (55,288) Trade names 28,878 (11,832) 23,966 (10,983) Software 78,122 (62,391) 80,203 (61,920) Other intangible assets 30,424 (22,799) 22,878 (22,545) $ 889,474 $ (401,481) $ 882,119 $ (382,584)
Schedule of Finite-Lived Intangible Assets	The following table summarizes the Company’s Intangible assets, excluding Goodwill. December 31, 2024 2023 Gross Accumulated Gross Accumulated (In thousands) Indefinite-Lived Intangible Assets: Trade names $ 173,912 $ — $ 185,301 $ — Definite-Lived Intangible Assets: Customer relationships 506,226 (248,920) 496,483 (231,848) Technology 71,912 (55,539) 73,288 (55,288) Trade names 28,878 (11,832) 23,966 (10,983) Software 78,122 (62,391) 80,203 (61,920) Other intangible assets 30,424 (22,799) 22,878 (22,545) $ 889,474 $ (401,481) $ 882,119 $ (382,584)
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The Company’s expected annual amortization expense for acquired intangible assets for the next five years is as follows. December 31, 2024 (In thousands) 2025 $ 30,754 2026 29,231 2027 25,626 2028 22,828 2029 21,399

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	December 31, Depreciable Life 2024 2023 (In years) (In thousands) Land n/a $ 14,484 $ 15,095 Buildings and improvements 5-40 176,077 178,682 Machinery and equipment 3-15 409,045 394,318 599,606 588,095 Accumulated depreciation (301,259) (293,790) $ 298,347 $ 294,305

Inventories, Net (Tables)

Inventories, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory	December 31, 2024 2023 (In thousands) Raw materials $ 151,248 $ 156,583 Work in process 41,698 43,561 Finished goods 251,994 244,580 444,940 444,724 LIFO reserve — (4,279) Less: allowance for excess, slow-moving and obsolete inventory (41,229) (47,587) $ 403,711 $ 392,858

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Future Minimum Lease Payments	December 31, 2024 (In thousands) Future lease payments by year: 2025 $ 24,478 2026 17,555 2027 12,403 2028 9,861 2029 8,438 Thereafter 25,628 Total 98,363 Less: present value discount (10,862) Present value of lease liabilities $ 87,501 Weighted-average remaining lease term (in years): Operating leases 6.18 Weighted-average discount rate: Operating leases 4.4 %

Accrued and Other Liabilities (

Accrued and Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Accrued Liabilities [Abstract]
Schedule of Accrued and Other Liabilities	Accrued and Other liabilities in the Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Current Noncurrent Current Noncurrent (In thousands) Accrued taxes and deferred tax liabilities $ 46,395 $ 151,642 $ 45,681 $ 144,662 Compensation and related benefits 80,451 48,350 97,052 52,589 Asbestos liability 40,779 253,287 32,908 234,796 Contract liability 26,390 — 31,248 — Lease liability 21,459 66,042 22,794 76,609 Warranty liability 12,794 — 12,606 — Third-party commissions 17,346 — 18,711 — Restructuring liability 4,732 374 5,345 354 Accrued interest 8,077 — 711 — Other 40,135 13,241 46,433 33,823 $ 298,558 $ 532,936 $ 313,489 $ 542,833
Schedule of Product Warranty Liability	The table below summarizes the activity in the Company’s warranty liability included in Accrued liabilities in the Company’s Consolidated Balance Sheets. Year Ended December 31, 2024 2023 (In thousands) Warranty liability, beginning of period $ 12,606 $ 12,946 Accrued warranty expense 10,570 5,794 Changes in estimates related to pre-existing warranties 1,624 3,097 Cost of warranty service work performed (11,426) (10,710) Foreign exchange translation effect and other (580) 1,479 Warranty liability, end of period $ 12,794 $ 12,606
Schedule of Restructuring Reserve by Type of Cost	The table below summarizes the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Consolidated Balance Sheets. Year Ended December 31, 2024 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 4,595 $ 4,538 $ (5,288) $ — $ 3,845 Facility closure costs and other (2) 1,104 5,689 (5,112) (420) 1,261 $ 5,699 $ 10,227 $ (10,400) $ (420) $ 5,106 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment and other costs in connection with the closure and optimization of facilities and product lines. Year Ended December 31, 2023 Balance at Beginning of Period Charges Payments Foreign Currency Translation Balance at End of Period (In thousands) Restructuring and other related charges: Termination benefits (1) $ 4,910 $ 10,017 $ (10,223) $ (109) $ 4,595 Facility closure costs (2) 2,908 8,637 (10,483) 42 1,104 Subtotal $ 7,818 18,654 $ (20,706) $ (67) $ 5,699 Non-cash charges (3) 5,456 $ 24,110 (1) Includes severance and other termination benefits, including outplacement services. (2) Includes the cost of relocating associates, relocating equipment, lease termination expenses and other costs in connection with the closure and optimization of facilities and product lines. (3) Includes impairment of long-lived assets in connection with the closure and optimization of facilities and product lines.

Benefit Plans (Tables)

Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Changes in Projected Benefit Obligations	The following table summarizes the total changes in the Company’s total and foreign pension benefits and plan assets and includes a statement of the plans’ funded status. All Pension Benefits Foreign Pension Benefits Year Ended December 31, Year Ended December 31, 2024 2023 2024 2023 (In thousands) Change in benefit obligation: Projected benefit obligation, beginning of year $ 242,743 $ 256,022 $ 99,215 $ 99,401 Service cost 1,429 1,439 1,429 1,439 Interest cost 8,828 11,170 2,576 4,148 Plan amendments (9) 175 (9) 175 Actuarial (gain) loss (5,945) 802 1,178 335 Foreign exchange effect (5,386) 4,079 (5,386) 4,079 Benefits paid (21,242) (27,720) (4,561) (7,138) Settlements (31,583) (3,584) (31,583) (3,584) Other 1,039 360 1,039 360 Projected benefit obligation, end of year 189,874 242,743 63,898 99,215 Accumulated benefit obligation, end of year $ 186,689 $ 239,578 $ 60,713 $ 96,049 Change in plan assets: Fair value of plan assets, beginning of year $ 211,472 $ 219,050 $ 65,278 $ 70,821 Actual return on plan assets 12,389 19,651 2,024 1,262 Employer contributions (1) 4,309 (857) 4,175 (1,015) Foreign exchange effect (2,028) 3,162 (2,028) 3,162 Benefits paid (21,242) (27,720) (4,561) (7,138) Settlements (43,283) (2,505) (43,283) (2,505) Other 289 691 289 691 Fair value of plan assets, end of year 161,906 211,472 21,894 65,278 Funded status, end of year $ (27,968) $ (31,271) $ (42,004) $ (33,937) Amounts recognized on the Consolidated Balance Sheets as of December 31: Non-current assets $ 17,228 $ 17,300 $ 2,072 $ 13,426 Current liabilities (3,113) (3,186) (2,979) (3,052) Non-current liabilities (42,083) (45,385) (41,097) (44,311) $ (27,968) $ (31,271) $ (42,004) $ (33,937) (1) The employer contribution amount for the year ended December 31, 2023 includes a refund of assets totaling $5.1 million to the Company arising from a completed wind up of a foreign defined benefit plan.
Schedule of Expected Benefit Payments	The table below includes the benefit payments that are expected to be paid during each respective fiscal year. Pension Benefits All Plans Foreign Plans (In thousands) 2025 $ 19,136 $ 5,735 2026 18,347 5,368 2027 17,986 5,455 2028 17,243 5,133 2029 16,917 5,309 2030 - 2034 76,386 26,156
Schedule of Allocation of Plan Assets	The table below shows the actual allocation percentages for the Company’s pension plan assets. Actual Asset Allocation 2024 2023 United States Plans: Equity securities: United States 37 % 38 % International 13 % 12 % Fixed income 50 % 49 % Cash and cash equivalents 0 % 1 % Foreign Plans: Equity securities 4 % 1 % Fixed income securities 15 % 48 % Cash and cash equivalents 1 % 1 % Insurance contracts 44 % 38 % Investment funds (1) 36 % 12 % (1) Represents various fixed income and equity securities. The table below summarizes the Company’s pension plan assets for each fair value hierarchy level for the periods presented (see Note 17, “Fai r Value Measurements” for further description of the levels within the fair value hierarchy). December 31, 2024 December 31, 2023 Measured at Net Asset Value (1) Level Level Level Measured at Net Asset Value (1) Level Level Level (In thousands) (In thousands) United States Plans: Cash and cash equivalents $ — $ 379 $ — $ — $ 379 $ — $ 1,237 $ — $ — $ 1,237 Equity securities: United States large cap 28,803 — — — 28,803 29,289 — — — 29,289 United States small/mid cap 9,456 13,481 — — 22,937 10,130 16,033 — — 26,163 International 17,566 — — — 17,566 18,078 — — — 18,078 Fixed income mutual funds: United States government and corporate 69,152 — — — 69,152 70,283 — — — 70,283 Other — 1,175 — — 1,175 — 1,145 — — 1,145 Foreign Plans: Cash and cash equivalents (2) — 238 — — 238 — 547 — — 547 Equity securities — 904 — — 904 — 921 — — 921 Non-United States government and corporate bonds — 3,198 — — 3,198 — 31,147 — — 31,147 Insurance contracts — — 9,608 — 9,608 — — 24,592 — 24,592 Investment funds — — 7,919 — 7,919 — — 8,050 — 8,050 Other — — 27 — 27 — — 20 — 20 $ 124,977 $ 19,375 $ 17,554 $ — $ 161,906 $ 127,780 $ 51,030 $ 32,662 $ — $ 211,472 (1) Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient (the “NAV”) have not been classified in the fair value hierarchy. These investments, consisting of common/collective trusts, are valued using the NAV provided by the Trustee. The NAV is based on the underlying investments held by the fund, which are traded in an active market, less its liabilities. These investments are able to be redeemed in the near-term. (2) The weighted-average interest crediting rates received in Cash and cash equivalents of foreign plans are immaterial relative to total plan assets.
Schedule of Net Benefit Costs	The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the Company’s total and foreign defined benefit pension plans. All Pension Benefits Foreign Pension Benefits Year Ended December 31, Year Ended December 31, 2024 2023 2022 2024 2023 2022 (In thousands) Components of Net Periodic Benefit Cost (Income): Service cost $ 1,429 $ 1,439 $ 1,684 $ 1,429 $ 1,439 $ 1,684 Interest cost 8,828 11,170 5,874 2,576 4,148 2,161 Amortization 1,634 1,206 4,313 130 40 687 Settlement loss (gain) 12,155 — (9,114) 12,155 — (9,114) Other (179) — 92 (179) (331) 92 Expected return on plan assets (9,410) (11,391) (11,519) (1,038) (2,475) (2,063) Net periodic benefit cost (income) $ 14,457 $ 2,424 $ (8,670) $ 15,073 $ 2,821 $ (6,553) Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Transfer from Former Parent (1) $ — $ — $ 53,134 $ — $ — $ — Current year net actuarial (gain) loss (9,598) (7,021) 949 (483) 1,984 (12,262) Current year prior service cost (9) 175 862 (9) 175 862 Less amounts included in net periodic benefit cost: Amortization of net (loss) (1,676) (1,575) (4,340) (172) (78) (714) Settlement / divestiture / other loss (455) (1,079) (67) (454) (1,079) (67) Amortization of prior service cost 42 38 (1,067) 42 38 (1,067) Total recognized in Other comprehensive income $ (11,696) $ (9,462) $ 49,471 $ (1,076) $ 1,040 $ (13,248) (1)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	The following table sets forth the components of net periodic benefit (income) cost and Other comprehensive income of the Company’s total and foreign defined benefit pension plans. All Pension Benefits Foreign Pension Benefits Year Ended December 31, Year Ended December 31, 2024 2023 2022 2024 2023 2022 (In thousands) Components of Net Periodic Benefit Cost (Income): Service cost $ 1,429 $ 1,439 $ 1,684 $ 1,429 $ 1,439 $ 1,684 Interest cost 8,828 11,170 5,874 2,576 4,148 2,161 Amortization 1,634 1,206 4,313 130 40 687 Settlement loss (gain) 12,155 — (9,114) 12,155 — (9,114) Other (179) — 92 (179) (331) 92 Expected return on plan assets (9,410) (11,391) (11,519) (1,038) (2,475) (2,063) Net periodic benefit cost (income) $ 14,457 $ 2,424 $ (8,670) $ 15,073 $ 2,821 $ (6,553) Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss: Transfer from Former Parent (1) $ — $ — $ 53,134 $ — $ — $ — Current year net actuarial (gain) loss (9,598) (7,021) 949 (483) 1,984 (12,262) Current year prior service cost (9) 175 862 (9) 175 862 Less amounts included in net periodic benefit cost: Amortization of net (loss) (1,676) (1,575) (4,340) (172) (78) (714) Settlement / divestiture / other loss (455) (1,079) (67) (454) (1,079) (67) Amortization of prior service cost 42 38 (1,067) 42 38 (1,067) Total recognized in Other comprehensive income $ (11,696) $ (9,462) $ 49,471 $ (1,076) $ 1,040 $ (13,248)
Schedule of Net Periodic Benefit Cost Not yet Recognized	The table below shows the components of net unrecognized pension benefit cost included in AOCL in the Consolidated Balance Sheets that have not been recognized as a component of net periodic benefit cost. Pension Benefits December 31, 2024 2023 (In thousands) Net actuarial loss $ 49,917 $ 61,573 Prior service income (122) (81) $ 49,795 $ 61,492
Schedule of Assumptions Used	The key economic assumptions used in the measurement of the Company’s pension benefits are included in the table below. Pension Benefits December 31, 2024 2023 Weighted-average discount rate: All plans 4.8 % 4.4 % Foreign plans 3.7 % 3.9 % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.1 % 3.1 % (1) Weighted-average rate of increase is only applicable to plans with compensation increase assumptions. The key economic assumptions used in the computation of net periodic benefit cost are as included in the table below. Pension Benefits Year Ended December 31, 2024 2023 2022 Weighted-average discount rate: All plans 4.4 % 4.6 % 2.2 % Foreign plans 3.9 % 4.3 % 1.9 % Weighted-average expected return on plan assets: All plans 5.1 % 5.0 % 4.8 % Foreign plans 4.4 % 4.1 % 3.2 % Weighted-average rate of increase in compensation levels for active foreign plans (1) 3.1 % 3.2 % 3.2 % (1)

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	debt. December 31, 2024 2023 (In thousands) Term loans $ 385,000 $ 987,500 Senior unsecured notes 700,000 — Revolving credit facility — 32,000 Total debt 1,085,000 1,019,500 Current portion of long-term debt (15,000) — Unamortized deferred financing fees (9,261) (1,443) Long-term debt $ 1,060,739 $ 1,018,057
Schedule of the Contractual Maturities of the Company's Debt	The Company’s minimum principal payments for the next five years are broken out in the table below. December 31, 2024 (in thousands) 2025 $ 15,000 2026 20,000 2027 350,000 2028 — 2029 700,000 Total debt (1) $ 1,085,000 (1) Total debt excludes $9.3 million of related unamortized deferred financing fees.

Derivatives (Tables)

Derivatives (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The table below shows the effects of designated cash flow hedges on the Company’s Consolidated and Combined Statements of Operations. Year Ended December 31, Derivative type (Gain) recognized in the Consolidated and Combined Statements of Operations 2024 2023 (In thousands) Interest rate swap agreement(s) Interest expense and other, net $ (9,104) $ (11,053)
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The table below shows the fair value of the derivatives recognized in the Company’s Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Designated as hedging instruments Other Liabilities Other Assets Other Liabilities Other Assets (In thousands) Cross-currency swap agreements $ 1,830 $ — $ 22,232 $ — Interest rate swap agreement(s) — 842 — 9,522 Total $ 1,830 $ 842 $ 22,232 $ 9,522
Derivatives Not Designated as Hedging Instruments	The table below shows the fair value of derivative instruments not designated in a hedging relationship recognized in the Company’s Consolidated Balance Sheets. December 31, 2024 December 31, 2023 Not designated as hedging instruments Accrued Liabilities Other Current Assets Accrued Liabilities Other Current Assets (In thousands) Foreign currency contracts $ 379 $ 255 $ 596 $ 1,088
Schedule of Derivative Instruments	The Company recognized the following in its Consolidated and Combined Financial Statements related to its derivative instruments not designated in a hedging relationship: Year Ended December 31, Foreign currency contracts 2024 2023 2022 (In thousands) Change in unrealized (loss) gain $ (616) $ (1,023) $ 1,338 Realized gain (loss) (1) $ 1,490 $ (2,928) $ (17,601) (1)
Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location	The table below shows the effects of the excluded components of designated net investment hedges on the Company’s Consolidated and Combined Statements of Operations. Year Ended December 31, Derivative type (Gain) recognized in the Consolidated and Combined Statements of Operations 2024 2023 Cross currency-swap agreements Interest expense and other, net $ (4,687) $ (4,779)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value	A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is in the table below (see Note 14, “Benefit Plan s” for classification of the assets of the Company’s benefit plans within the fair value hierarchy). December 31, 2024 December 31, 2023 Level Level Level Total Level Level Level Total (In thousands) (In thousands) Assets: Cash equivalents $ 8,990 $ — $ — $ 8,990 $ 6,027 $ — $ — $ 6,027 Foreign currency contracts — 657 — 657 — 2,261 — 2,261 Interest rate swap agreement — 842 — 842 — 9,522 — 9,522 Deferred compensation plans — 5,242 — 5,242 — 3,488 — 3,488 $ 8,990 $ 6,741 $ — $ 15,731 $ 6,027 $ 15,271 $ — $ 21,298 Liabilities: Foreign currency contracts $ — $ 781 $ — $ 781 $ — $ 1,769 $ — $ 1,769 Cross-currency swap agreements — 1,830 — 1,830 — 22,232 — 22,232 Deferred compensation plans — 5,242 — 5,242 — 3,488 — 3,488 $ — $ 7,853 $ — $ 7,853 $ — $ 27,489 $ — $ 27,489

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The following table presents the changes in the balances of each component of AOCL including reclassifications out of AOCL for the years ended December 31, 2024, 2023 and 2022. All amounts are net of tax and noncontrolling interest, if any. Accumulated Other Comprehensive Loss Components Net Unrecognized Pension and Other Post-Retirement Benefit Cost Foreign Currency Translation Adjustment Net Investment Hedges Cash Flow Hedges Total (In thousands) Balance at January 1, 2022 $ (21,196) $ (439,692) $ — $ — $ (460,888) Other comprehensive (loss) income before reclassifications: Amounts contributed by Former Parent (2) (50,504) (8,759) — — (59,263) Net actuarial gain 113 — — — 113 Foreign currency translation adjustment 1,712 (82,351) (8,336) — (88,975) Loss on long-term intra-entity foreign currency transactions — (83,105) — — (83,105) Unrealized gain on cash flow hedges — — — 10,782 10,782 Other comprehensive (loss) income before reclassifications (48,679) (174,215) (8,336) 10,782 (220,448) Amounts reclassified from Accumulated other comprehensive loss ((1)(3) 6,028 — — 320 6,348 Net current period Other comprehensive (loss) income (42,651) (174,215) (8,336) 11,102 (214,100) Balance at December 31, 2022 (63,847) (613,907) (8,336) 11,102 (674,988) Other comprehensive income (loss) before reclassifications: Net actuarial gain 8,969 — — — 8,969 Foreign currency translation adjustment (3,285) (11,143) (8,879) — (23,307) Gain on long-term intra-entity foreign currency transactions — 70,428 — — 70,428 Unrealized gain on cash flow hedges — — — 4,834 4,834 Other comprehensive income (loss) before reclassifications 5,684 59,285 (8,879) 4,834 60,924 Amounts reclassified from Accumulated other comprehensive loss (1)(3) (1,642) — — (8,566) (10,208) Net current period Other comprehensive income (loss) 4,042 59,285 (8,879) (3,732) 50,716 Balance at December 31, 2023 (59,805) (554,622) (17,215) 7,370 (624,272) Other comprehensive income (loss) before reclassifications: Net actuarial gain 9,069 — — — 9,069 Foreign currency translation adjustment 530 (137,599) 15,968 — (121,101) Gain on long-term intra-entity foreign currency transactions — 14,136 — — 14,136 Unrealized gain on cash flow hedges — — — 4,426 4,426 Other comprehensive income (loss) before reclassifications 9,599 (123,463) 15,968 4,426 (93,470) Amounts reclassified from Accumulated other comprehensive loss (1)(3) (146) — — (9,980) (10,126) Purchase related to noncontrolling interest — (1,706) — — (1,706) Net current period Other comprehensive income (loss) 9,453 (125,169) 15,968 (5,554) (105,302) Balance at December 31, 2024 $ (50,352) $ (679,791) $ (1,247) $ 1,816 $ (729,574) (1) The amounts on this line within the Net Unrecognized Pension and Other Post-Retirement Benefit Cost column are included in the computation of net periodic benefit cost. See Note 14, “Benefit Plans” for additional details. (2) Includes unrecognized pension and other post-retirement costs and accumulated currency translation adjustments of certain entities that were part of the Corporate segment of the Former Parent and were transferred to ESAB Corporation in anticipation of the Separation. (3) The amounts on this line within the Cash Flow Hedges column are a component of Interest expense and other, net. See Note 16, “Derivatives,” for additional details.
Schedule of Nonvested Share Activity	The activity of the Company’s PRSUs and RSUs is included in the table below. PRSUs RSUs Number of Units Weighted- Average Number of Units Weighted-Average Balance at December 31, 2023 143,875 $ 55.86 464,730 $ 55.21 Granted 56,767 100.33 122,155 95.23 Vested — — (191,802) 56.54 Forfeited and expired — — (21,463) 65.79 Balance at December 31, 2024 200,642 $ 68.44 373,620 $ 67.02

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Loss Contingencies By Claims Quantities	Asbestos-related claims activity since December 31, 2023 and 2022, respectively. Year Ended December 31, 2024 2023 (Number of claims) Claims unresolved, beginning of period 13,648 14,106 Claims filed (1) 5,005 4,627 Claims resolved (2) (4,895) (5,085) Claims unresolved, end of period 13,758 13,648 (In dollars) Average cost of resolved claims (3) $ 10,574 $ 9,524 (1) Claims filed include all asbestos claims for which notification has been received or a file has been opened. (2) Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants. (3) Excludes claims settled in Mississippi for which the majority of claims have historically been resolved for no payment and insurance recoveries.
Schedule Of Asbestos Related Litigation	Company’s Consolidated Balance Sheets include the amounts related to asbestos-related litigation shown in the table below. December 31, 2024 2023 (In thousands) Long-term asbestos insurance asset (1) $ 234,951 $ 221,489 Long-term asbestos insurance receivable (1) 16,961 17,868 Accrued asbestos liability (2) 40,779 32,908 Long-term asbestos liability (3) $ 253,287 $ 234,796 (1) Included in Other assets in the Consolidated Balance Sheets. (2) Represents current accruals for probable and reasonably estimable asbestos-related liability costs that the Company believes the subsidiaries will pay and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Consolidated Balance Sheets. (3) Included in Other liabilities in the Consolidated Balance Sheets.

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The Company’s segment results are included in the table below. Year Ended December 31, 2024 2023 2022 (In thousands) Net sales (1) : Americas $ 1,176,745 $ 1,214,998 $ 1,128,306 EMEA & APAC 1,564,058 1,559,768 1,465,174 $ 2,740,803 $ 2,774,766 $ 2,593,480 Cost of sales: Americas $ 711,082 $ 760,134 $ 752,641 EMEA & APAC 992,266 998,881 955,309 $ 1,703,348 $ 1,759,015 $ 1,707,950 Allocated corporate overhead operating expense: Americas $ 64,517 $ 64,668 $ 55,328 EMEA & APAC 97,807 103,984 85,527 $ 162,324 $ 168,652 $ 140,855 Other operating expense: Americas $ 161,946 $ 165,454 $ 131,760 EMEA & APAC 184,411 180,543 176,161 $ 346,357 $ 345,997 $ 307,921 Adjusted EBITDA (2) : Americas $ 239,200 $ 224,742 $ 188,577 EMEA & APAC 289,574 276,360 248,177 $ 528,774 $ 501,102 $ 436,754 Depreciation, amortization and other impairment charges: Americas $ 31,193 $ 34,589 $ 29,281 EMEA & APAC 35,978 40,445 36,697 $ 67,171 $ 75,034 $ 65,978 Capital expenditures: Americas $ 22,648 $ 21,576 $ 18,005 EMEA & APAC 29,131 26,602 22,238 $ 51,779 $ 48,178 $ 40,243 (1) For the years ended December 31, 2024, 2023 and 2022, the total Net sales originating from the United States were $595.6 million, $619.1 million and $583.0 million, respectively. (2) The following is a reconciliation of Net income from continuing operations to Adjusted EBITDA: Year Ended December 31, 2024 2023 2022 (In thousands) Net income from continuing operations $ 293,057 $ 223,365 $ 231,081 Income tax expense 77,348 95,727 69,170 Interest expense and other, net 64,890 85,074 37,950 Pension settlement loss (gain) 12,155 — (9,136) Restructuring and other related charges (1) 10,227 24,110 23,096 Separation costs (2) — — 15,545 Acquisition - amortization and other related charges (3) 34,479 36,851 34,196 Depreciation and other amortization 36,618 35,975 34,852 Adjusted EBITDA $ 528,774 $ 501,102 $ 436,754 (1) I ncludes severance and other termination benefits, including outplacement services, as well as the cost of relocating associates, relocating equipment, lease termination expenses, impairment of long-lived assets and other costs in connection with the closure and optimization of facilities and product lines . (2) I ncludes non-recurrin g charges and employee costs related to the planning and execution of t he Separation within the Selling, general and administrative expense line within the Consolidated and Combined Statements of Operations. (3) Includes transaction expenses, amortization of intangibles, fair value charges on acquired inventories and integration expenses. December 31, 2024 2023 (In thousands) Investments in equity method investees: Americas $ — $ — EMEA & APAC 28,885 30,633 $ 28,885 $ 30,633 Total assets: Americas $ 1,796,167 $ 1,671,634 EMEA & APAC 2,237,808 2,156,995 $ 4,033,975 $ 3,828,629
Schedule of Long-Lived Assets, by Geographical Areas	December 31, 2024 2023 (In thousands) Property, plant and equipment, net (1) : United States $ 73,036 $ 68,398 Czech Republic 55,554 60,948 India 31,506 31,258 Mexico 20,495 23,922 Poland 17,227 14,661 Russia 12,225 15,550 Other foreign countries 88,304 79,568 $ 298,347 $ 294,305 (1) As the Company does not allocate all long-lived assets, specifically intangible assets, to each individual country, evaluation of long-lived assets in total is impracticable.

Organization and Basis of Pre_2

Organization and Basis of Presentation (Details) $ in Thousands		12 Months Ended
	Apr. 04, 2022 shares	Dec. 31, 2024 USD ($) segment	Dec. 31, 2023 USD ($)
Concentration Risk [Line Items]
Number of reportable segments | segment		2
Net income		$ 264,842	$ 205,285
Stockholders' Equity Attributable to Parent		(1,769,004)	(1,607,399)
Cash and cash equivalents		249,358	$ 102,003
Foreign Currency Translation Adjustment
Concentration Risk [Line Items]
Stockholders' Equity Attributable to Parent		130,000
Russia
Concentration Risk [Line Items]
Net income		13,000
Cash and cash equivalents		$ 30,000
Russia | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk (as a percent)		5%
Russia | Assets, Total | Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk (as a percent)		4%
Common Stock
Concentration Risk [Line Items]
Percentage of outstanding stock after spin-off	90%
Common Stock | Enovis Corporation
Concentration Risk [Line Items]
Number of shares recapitalized | shares	0.333

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	12 Months Ended
	Dec. 31, 2024 USD ($) reporting_unit	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Incremental costs of obtaining a contract, period	1 year
Research and development costs	$ 39,200,000	$ 38,800,000	$ 36,000,000
LIFO inventory amount		107,800,000
LIFO expense amount		2,100,000	3,300,000
Cost of sales	1,703,348,000	1,759,015,000	1,707,950,000
Reserve for excess and obsolete inventory	$ 41,229,000	47,587,000
Number of reporting units | reporting_unit	3
Goodwill impairment	$ 0	0	0
Foreign exchange gain (loss)	6,978,000	13,108,000	2,706,000
Cumulative Effect, Period of Adoption, Adjustment
Cost of sales	4,300,000
Trade names
Impairment of intangible assets, indefinite-lived	0	0	0
Selling, general and administrative expense
Foreign exchange gain (loss)	7,136,000	11,389,000	2,597,000
Interest expense and other, net
Foreign exchange gain (loss)	(158,000)	1,719,000	109,000
Argentina, Pesos | Cost of Sales
Foreign exchange gain (loss)	8,900,000	11,500,000	6,600,000
Argentina, Pesos | Selling, general and administrative expense
Foreign exchange gain (loss)	600,000	6,700,000	3,300,000
Argentina, Pesos | Interest expense and other, net
Foreign exchange gain (loss)	$ 300,000	$ 26,200,000	$ 2,400,000
Minimum | Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements
Intangible asset, useful life (in years)	5 years
Maximum | Acquired Trade names, Customer Relationships, Acquired Technology and Software License Agreements
Intangible asset, useful life (in years)	30 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Net Foreign Transaction Gains and Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	$ 6,978	$ 13,108	$ 2,706
Selling, general and administrative expense
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	7,136	11,389	2,597
Selling, general and administrative expense | Argentina, Pesos
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	600	6,700	3,300
Interest expense and other, net
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	(158)	1,719	109
Interest expense and other, net | Argentina, Pesos
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	300	26,200	2,400
Cost of Sales | Argentina, Pesos
Change in Accounting Estimate [Line Items]
Foreign currency transaction loss, net(2)	$ 8,900	$ 11,500	$ 6,600

Discontinued Operations - Narra

Discontinued Operations - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Cash used in operating activities, discontinued operations	$ 15	$ 15.2	$ 23.1

Acquisitions (Details)

Acquisitions (Details) - USD ($) $ in Thousands							12 Months Ended
	Oct. 31, 2024	Jul. 02, 2024	Feb. 26, 2024	Jan. 11, 2023	Oct. 31, 2022	Oct. 14, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Cash consideration, net of cash received							$ 153,664	$ 18,665	$ 149,029
Goodwill							$ 1,651,993	$ 1,588,331	$ 1,529,767
SUMIG Soluções para Solda e Corte Ltda
Business Acquisition [Line Items]
Cash consideration, net of cash received	$ 68,000
Goodwill	37,000
Intangible assets	$ 23,000
Linde Industries Private Limited
Business Acquisition [Line Items]
Goodwill		$ 46,000
Purchase price		69,000
Intangible assets		$ 15,000
Sager S.A.
Business Acquisition [Line Items]
Purchase price			$ 18,000
Therapy Equipment Limited
Business Acquisition [Line Items]
Cash consideration, net of cash received				$ 19,000
Swift Cut Automation Limited
Business Acquisition [Line Items]
Cash consideration, net of cash received					$ 22,000
Ohio Medical, LLC
Business Acquisition [Line Items]
Cash consideration, net of cash received						$ 127,000
Goodwill						60,000
Intangible assets						$ 50,000

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 2,740,803	$ 2,774,766	$ 2,593,480
Equipment
Disaggregation of Revenue [Line Items]
Net sales	1,847,490	854,949	740,824
Consumables
Disaggregation of Revenue [Line Items]
Net sales	$ 893,313	$ 1,919,817	$ 1,852,656

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Contract liability	$ 26.4	$ 31.2	$ 25.9

Revenue - Allowance for Credit

Revenue - Allowance for Credit Loss Rollforward (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	$ 25,477
Charged to Expense, net	2,248
Write-Offs and Deductions	(2,423)
Foreign Currency Translation	(1,452)
Balance at End of Period	$ 23,850

Earnings per Share from Conti_3

Earnings per Share from Continuing Operations (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Computation of earnings per share from continuing operations – basic:
Income from continuing operations attributable to ESAB Corporation	$ 287,151	$ 217,626	$ 226,815
Less: distributed and undistributed earnings allocated to nonvested shares	(1,370)	(1,555)	(1,600)
Income from continuing operations attributable to common stockholders	$ 285,781	$ 216,071	$ 225,215
Weighted-average shares of common stock outstanding - basic (in shares)	60,427,743	60,233,623	60,054,930
Income per share from continuing operations – basic (in dollars per share)	$ 4.73	$ 3.59	$ 3.75
Computation of earnings (loss) per share from continuing operations – diluted:
Net effect of potentially dilutive securities (in shares)	674,320	422,123	98,129
Weighted-average shares of common stock outstanding - assuming dilution (in shares)	61,102,063	60,655,746	60,153,059
Income per share from continuing operations – assuming dilution (in dollars per share)	$ 4.68	$ 3.56	$ 3.74
Income attributable to noncontrolling interest, net of taxes	$ 5,906	$ 5,739	$ 4,266

Income Taxes - Components of In

Income Taxes - Components of Income Before Taxes and Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income from continuing operations before income taxes:
Domestic operations	$ 50,212	$ 37,364	$ (19,234)
Foreign operations	320,193	281,728	319,485
Income from continuing operations before income taxes	370,405	319,092	300,251
Current:
Federal	15,717	18,034	8,928
State	2,635	3,760	2,451
Foreign	58,761	99,036	77,728
Current income tax	77,113	120,830	89,107
Deferred:
Federal	2,489	(11,897)	(7,501)
State	(126)	(1,341)	358
Foreign	(2,128)	(11,865)	(12,794)
Deferred Income Tax	235	(25,103)	(19,937)
Income tax expense	$ 77,348	$ 95,727	$ 69,170

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Taxes calculated at the United States federal statutory rate	$ 77,785	$ 67,010	$ 63,053
State taxes	1,956	1,630	2,809
Effect of tax rates on international operations	1,823	1,548	(9,010)
Changes in tax reserves	(4,206)	10,753	(350)
Research and development tax credits	(980)	(714)	(542)
Effect of United States taxation on international operations	5,239	1,527	310
Permanent differences, net	(4,061)	10,077	7,209
Provision to return	(8,350)	703	(7,055)
Withholding taxes	6,634	11,172	12,133
Capital gain	0	0	(3,655)
Valuation Allowance	(761)	(12,308)	4,503
Other	2,269	4,329	(235)
Income tax expense	$ 77,348	$ 95,727	$ 69,170

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets:
Post-retirement benefit obligation	$ 1,229	$ 1,350
Expenses currently not deductible	59,518	52,526
Net operating loss carryforward	86,716	107,395
Tax credit carryforward	5,137	4,581
Depreciation and amortization	4,286	7,404
Inventory	10,795	12,238
Capitalized R&D costs	20,556	18,178
Leases	21,490	23,987
Other	0	2,867
Valuation allowance	(65,007)	(79,355)
Deferred tax assets, net	144,720	151,171
Deferred tax liabilities:
Depreciation and amortization	(125,227)	(120,055)
Leases	(22,084)	(23,987)
Outside basis differences and other	(87,434)	(79,985)
Total deferred tax liabilities	(234,745)	(224,027)
Total deferred tax liabilities, net	$ (90,025)	$ (72,856)

Income Taxes - Deferred Tax A_2

Income Taxes - Deferred Tax Assets and Liabilities Balance Sheet Items (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Income Tax Examination [Line Items]
Other liabilities	$ (151,642)	$ (144,662)
Total deferred tax liabilities, net	(90,025)	(72,856)
Other Assets
Income Tax Examination [Line Items]
Other assets	44,816	46,602
Other Liabilities
Income Tax Examination [Line Items]
Other liabilities	$ (134,841)	$ (119,458)

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Examination [Line Items]
Percentage of liable taxes in a joint return	50%
Valuation allowance	$ 65,007	$ 79,355
Valuation allowance on deferred taxes	12,500
Net operating loss carryforward, subject to expiration	5,100
Unrecognized tax benefits	17,084	30,871	$ 20,203	$ 37,681
Unrecognized tax benefits, income tax penalties and interest accrued	4,700	12,100	5,600
Unrecognized tax (benefits), income tax penalties and interest expense	$ 6,200	$ 7,900	$ 700
Effective Income Tax Rate Reconciliation, Percent	20.90%	30%	23%
Foreign Tax Authority
Income Tax Examination [Line Items]
Operating loss carryforwards	$ 331,100

Income Taxes - Gross Unrecogniz

Income Taxes - Gross Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning Balance	$ 30,871	$ 20,203	$ 37,681
Addition for tax positions taken in prior periods	6,436	13,514	1,971
Addition for tax positions taken in the current period			1,171
Reductions for tax positions taken in prior periods	(7,825)
Reductions related to settlements with taxing authorities	(9,255)	(4,160)	(922)
Reductions resulting from a lapse of applicable statute of limitations	(51)		(2,801)
Transfer from Former Parent, impact of foreign currency translation and other		(473)
Other, including the impact of foreign currency translation and United States tax rate changes		1,787	16,897
Other, including the impact of foreign currency translation	(3,092)
Ending Balance	$ 17,084	$ 30,871	$ 20,203

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Balance beginning of period	$ 1,588,331	$ 1,529,767
Goodwill attributable to acquisition	91,196	15,576
Impact of foreign currency translation	(27,534)	42,988
Balance end of period	1,651,993	1,588,331
Americas Business Segment [Member]
Goodwill [Roll Forward]
Balance beginning of period	589,875	585,845
Goodwill attributable to acquisition	44,505	1,664
Impact of foreign currency translation	(4,675)	2,366
Balance end of period	629,705	589,875
EMEA & APAC
Goodwill [Roll Forward]
Balance beginning of period	998,456	943,922
Goodwill attributable to acquisition	46,691	13,912
Impact of foreign currency translation	(22,859)	40,622
Balance end of period	$ 1,022,288	$ 998,456

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Intangible Assets Schedule [Line Items]
Accumulated Amortization	$ (401,481)	$ (382,584)
Total intangible assets	889,474	882,119
Trade names
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	28,878	23,966
Accumulated Amortization	(11,832)	(10,983)
Customer relationships
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	506,226	496,483
Accumulated Amortization	(248,920)	(231,848)
Technology
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	71,912	73,288
Accumulated Amortization	(55,539)	(55,288)
Software
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	78,122	80,203
Accumulated Amortization	(62,391)	(61,920)
Other intangible assets
Intangible Assets Schedule [Line Items]
Gross Carrying Amount	30,424	22,878
Accumulated Amortization	(22,799)	(22,545)
Trade names
Intangible Assets Schedule [Line Items]
Indefinite-Lived Intangible Assets:	$ 173,912	$ 185,301

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 36	$ 39.7	$ 35.6

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Expected Amortization Expense (Details ) $ in Thousands	Dec. 31, 2024 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Intangible Asset, Expected Amortization, Year One	$ 30,754
Finite-Lived Intangible Asset, Expected Amortization, Year Two	29,231
Finite-Lived Intangible Asset, Expected Amortization, Year Three	25,626
Finite-Lived Intangible Asset, Expected Amortization, Year Four	22,828
47483	$ 21,399

Property, Plant and Equipment_3

Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 599,606	$ 588,095
Accumulated depreciation	(301,259)	(293,790)
Property, plant and equipment, net	298,347	294,305
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	14,484	15,095
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 176,077	178,682
Buildings and improvements | Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life	5 years
Buildings and improvements | Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life	40 years
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 409,045	$ 394,318
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Depreciable Life	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Depreciable Life	15 years

Property, Plant and Equipment_4

Property, Plant and Equipment, Net - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and other amortization	$ 30.6	$ 30	$ 29.5

Inventories, Net (Details)

Inventories, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 151,248	$ 156,583
Work in process	41,698	43,561
Finished goods	251,994	244,580
Inventories, gross	444,940	444,724
LIFO reserve	0	(4,279)
Less: allowance for excess, slow-moving and obsolete inventory	(41,229)	(47,587)
Inventories, net	$ 403,711	$ 392,858
Percentage of inventory valued at LIFO		27.40%

Leases (Details)

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Operating lease expense	$ 24,900	$ 25,400	$ 21,300
Future lease payments by year:
46022	24,478
46387	17,555
46752	12,403
47118	9,861
47483	8,438
Thereafter	25,628
Total	98,363
Less: present value discount	(10,862)
Present value of lease liabilities	$ 87,501
Lessee, Operating Lease, Remaining Lease Term	6 years 2 months 4 days
Operating leases	4.40%

Accrued and Other Liabilities -

Accrued and Other Liabilities - Current and Noncurrent (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT LIABILITIES:
Accrued taxes and deferred tax liabilities	$ 46,395	$ 45,681
Compensation and related benefits	80,451	97,052
Asbestos liability	40,779	32,908
Contract liability	26,390	31,248
Lease liability	21,459	22,794
Warranty liability	12,794	12,606
Third-party commissions	17,346	18,711
Restructuring liability	4,732	5,345
Other	40,135	46,433
Accrued liabilities	$ 298,558	$ 313,489
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Liabilities, Noncurrent [Abstract]
Accrued taxes and deferred tax liabilities	$ 151,642	$ 144,662
Compensation and related benefits	48,350	52,589
Asbestos liability	253,287	234,796
Contract liability	$ 0	$ 0
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Total accrued and other liabilities, Noncurrent	Total accrued and other liabilities, Noncurrent
Lease liability	$ 66,042	$ 76,609
Warranty liability	0	0
Third-party commissions	0	0
Restructuring liability	374	354
Other	13,241	33,823
Total accrued and other liabilities, Noncurrent	532,936	542,833
Interest Payable, Current	8,077	711
Interest Payable, Noncurrent	$ 0	$ 0

Accrued and Other Liabilities_2

Accrued and Other Liabilities - Warranty Liability Rollforward (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 29, 2024	Dec. 31, 2024	Dec. 31, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]
Warranty liability, beginning of period	$ 12,606	$ 12,606	$ 12,946
Accrued warranty expense	10,570		5,794
Changes in estimates related to pre-existing warranties	1,624		3,097
Cost of warranty service work performed	$ (11,426)		(10,710)
Foreign exchange translation effect and other		(580)	1,479
Warranty liability, end of period		$ 12,794	$ 12,606

Accrued and Other Liabilities_3

Accrued and Other Liabilities - Restructuring Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring Reserve [Roll Forward]
Restructuring Charges, Total	$ 10,227	$ 24,110	$ 23,096
Americas Business Segment [Member]
Restructuring Reserve [Roll Forward]
Balance at Beginning of Period	5,699	7,818
Charges	10,227	18,654
Payments	(10,400)	(20,706)
Foreign Currency Translation	(420)	(67)
Balance at End of Period	5,106	5,699	7,818
Non cash charges		5,456
Restructuring Charges, Total		24,110
Termination Benefits | Americas Business Segment [Member]
Restructuring Reserve [Roll Forward]
Balance at Beginning of Period	4,595	4,910
Charges	4,538	10,017
Payments	(5,288)	(10,223)
Foreign Currency Translation	0	(109)
Balance at End of Period	3,845	4,595	4,910
Facility Closure Costs | Americas Business Segment [Member]
Restructuring Reserve [Roll Forward]
Balance at Beginning of Period	1,104	2,908
Charges	5,689	8,637
Payments	(5,112)	(10,483)
Foreign Currency Translation	(420)	42
Balance at End of Period	$ 1,261	$ 1,104	$ 2,908

Benefit Plans - Narrative (Deta

Benefit Plans - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($) plan	Dec. 31, 2022 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of plans merged | plan		2
Number of plans after merging plans | plan		1
Pension settlement gain	$ (12,155)	$ 0	$ 9,136
Plans with accumulated benefit obligations in excess of plan assets, accumulated benefit obligation	49,300	50,700
Plans with accumulated benefit obligations in excess of plan assets, fair value of plan assets	6,300	3,900
Plans with projected benefit obligations in excess of plan assets, projected benefit obligation	52,400	55,600
Plans with projected benefit obligations in excess of plan assets, fair value of plan assets	7,200	7,000
Expected employer contributions in the next fiscal year	4,500
Defined contribution plan, cost	7,500	7,600	8,700
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	161,906	211,472
All Pension Benefits
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	161,906	211,472	219,050
Change in benefit obligation:	189,874	242,743	256,022
Pretax net unrecognized pension and other post-retirement benefit cost included in accumulated other comprehensive loss	49,795	61,492
Pension settlement gain	(12,155)	0	9,114
All Pension Benefits | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	21,894	65,278	70,821
Change in benefit obligation:	63,898	99,215	99,401
Pension settlement gain	$ (12,200)	$ 0	$ 9,114

Benefit Plans - Obligation and

Benefit Plans - Obligation and Asset Rollforward (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in plan assets:
Employer contribution from refund of assets	$ 5,100
Pension settlement gain	(12,155)	$ 0	$ 9,136
Foreign Plan
Change in plan assets:
Fair value of plan assets, beginning of year	211,472
Fair value of plan assets, end of year	161,906	211,472
All Pension Benefits
Change in benefit obligation:
Projected benefit obligation, beginning of year	242,743	256,022
Service cost	1,429	1,439	1,684
Interest cost	8,828	11,170	5,874
Plan amendments	(9)	175
Actuarial (gain) loss	(5,945)	802
Foreign exchange effect	(5,386)	4,079
Benefits paid	(21,242)	(27,720)
Settlements	(31,583)	(3,584)
Other	1,039	360
Projected benefit obligation, end of year	189,874	242,743	256,022
Accumulated benefit obligation, end of year	186,689	239,578
Change in plan assets:
Fair value of plan assets, beginning of year	211,472	219,050
Actual return on plan assets	12,389	19,651
Employer contributions	4,309
Employer contributions		(857)
Foreign exchange effect	(2,028)	3,162
Benefits paid	(21,242)	(27,720)
Settlements	(43,283)	(2,505)
Other	289	691
Fair value of plan assets, end of year	161,906	211,472	219,050
Funded status, end of year	(27,968)	(31,271)
Non-current assets	17,228	17,300
Current liabilities	(3,113)	(3,186)
Non-current liabilities	(42,083)	(45,385)
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position, Total	(27,968)	(31,271)
Pension settlement gain	(12,155)	0	9,114
All Pension Benefits | Foreign Plan
Change in benefit obligation:
Projected benefit obligation, beginning of year	99,215	99,401
Service cost	1,429	1,439	1,684
Interest cost	2,576	4,148	2,161
Plan amendments	(9)	175
Actuarial (gain) loss	1,178	335
Foreign exchange effect	(5,386)	4,079
Benefits paid	(4,561)	(7,138)
Settlements	(31,583)	(3,584)
Other	1,039	360
Projected benefit obligation, end of year	63,898	99,215	99,401
Accumulated benefit obligation, end of year	60,713	96,049
Change in plan assets:
Fair value of plan assets, beginning of year	65,278	70,821
Actual return on plan assets	2,024	1,262
Employer contributions	4,175
Employer contributions		(1,015)
Foreign exchange effect	(2,028)	3,162
Benefits paid	(4,561)	(7,138)
Settlements	(43,283)	(2,505)
Other	289	691
Fair value of plan assets, end of year	21,894	65,278	70,821
Funded status, end of year	(42,004)	(33,937)
Non-current assets	2,072	13,426
Current liabilities	(2,979)	(3,052)
Non-current liabilities	(41,097)	(44,311)
Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position, Total	(42,004)	(33,937)
Pension settlement gain	$ (12,200)	$ 0	$ 9,114

Benefit Plans - Expected Benefi

Benefit Plans - Expected Benefit Payments (Details) - All Pension Benefits $ in Thousands	Dec. 31, 2024 USD ($)
Defined Benefit Plan Disclosure [Line Items]
2025	$ 19,136
2026	18,347
2027	17,986
2028	17,243
2029	16,917
2030 - 2034	76,386
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
2025	5,735
2026	5,368
2027	5,455
2028	5,133
2029	5,309
2030 - 2034	$ 26,156

Benefit Plans - Plan Asset Allo

Benefit Plans - Plan Asset Allocation (Details)	Dec. 31, 2024	Dec. 31, 2023
Equity securities | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	4%	1%
United States | United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	37%	38%
International | United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	13%	12%
Fixed income | United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	50%	49%
Fixed income | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	15%	48%
Cash and cash equivalents | United States
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	0%	1%
Cash and cash equivalents | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	1%	1%
Insurance contracts | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	44%	38%
Investment funds | Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Actual asset allocation	36%	12%

Benefit Plans - Plan Asset Al_2

Benefit Plans - Plan Asset Allocation, Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
United States | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	$ 379	$ 1,237
United States | United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	28,803	29,289
United States | United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	22,937	26,163
United States | International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	17,566	18,078
United States | United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	69,152	70,283
United States | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	1,175	1,145
United States | Measured at Net Asset Value | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Measured at Net Asset Value | United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	28,803	29,289
United States | Measured at Net Asset Value | United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	9,456	10,130
United States | Measured at Net Asset Value | International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	17,566	18,078
United States | Measured at Net Asset Value | United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	69,152	70,283
United States | Measured at Net Asset Value | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level One | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	379	1,237
United States | Level One | United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level One | United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	13,481	16,033
United States | Level One | International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level One | United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level One | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	1,175	1,145
United States | Level Two | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Two | United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Two | United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Two | International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Two | United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Two | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Three | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Three | United States large cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Three | United States small/mid cap
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Three | International
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Three | United States government and corporate
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
United States | Level Three | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	161,906	211,472
Foreign Plan | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	238	547
Foreign Plan | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	904	921
Foreign Plan | Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	3,198	31,147
Foreign Plan | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	9,608	24,592
Foreign Plan | Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	7,919	8,050
Foreign Plan | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	27	20
Foreign Plan | Measured at Net Asset Value
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	124,977	127,780
Foreign Plan | Measured at Net Asset Value | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Measured at Net Asset Value | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Measured at Net Asset Value | Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Measured at Net Asset Value | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Measured at Net Asset Value | Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Measured at Net Asset Value | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level One
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	19,375	51,030
Foreign Plan | Level One | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	238	547
Foreign Plan | Level One | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	904	921
Foreign Plan | Level One | Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	3,198	31,147
Foreign Plan | Level One | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level One | Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level One | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Two
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	17,554	32,662
Foreign Plan | Level Two | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Two | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Two | Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Two | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	9,608	24,592
Foreign Plan | Level Two | Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	7,919	8,050
Foreign Plan | Level Two | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	27	20
Foreign Plan | Level Three
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Three | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Three | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Three | Non-United States government and corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Three | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Three | Investment funds
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	0	0
Foreign Plan | Level Three | Other
Defined Benefit Plan Disclosure [Line Items]
Pension plan assets	$ 0	$ 0

Benefit Plans - Net Periodic Be

Benefit Plans - Net Periodic Benefit Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Components of Net Periodic Benefit Cost (Income):
Settlement loss (gain)	$ 12,155	$ 0	$ (9,136)
All Pension Benefits
Components of Net Periodic Benefit Cost (Income):
Service cost	1,429	1,439	1,684
Interest cost	8,828	11,170	5,874
Amortization	1,634	1,206	4,313
Settlement loss (gain)	12,155	0	(9,114)
Other	(179)	0	92
Expected return on plan assets	(9,410)	(11,391)	(11,519)
Net periodic benefit cost (income)	14,457	2,424	(8,670)
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent	0	0	53,134
Current year net actuarial (gain) loss	(9,598)	(7,021)	949
Current year prior service cost	(9)	175	862
Less amounts included in net periodic benefit cost:
Amortization of net (loss)	(1,676)	(1,575)	(4,340)
Settlement / divestiture / other loss	(455)	(1,079)	(67)
Amortization of prior service cost	42	38	(1,067)
Total recognized in Other comprehensive income	(11,696)	(9,462)	49,471
Foreign Plan | All Pension Benefits
Components of Net Periodic Benefit Cost (Income):
Service cost	1,429	1,439	1,684
Interest cost	2,576	4,148	2,161
Amortization	130	40	687
Settlement loss (gain)	12,200	0	(9,114)
Other	(179)	(331)	92
Expected return on plan assets	(1,038)	(2,475)	(2,063)
Net periodic benefit cost (income)	15,073	2,821	(6,553)
Change in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Gain) Loss:
Transfer from Former Parent	0	0	0
Current year net actuarial (gain) loss	(483)	1,984	(12,262)
Current year prior service cost	(9)	175	862
Less amounts included in net periodic benefit cost:
Amortization of net (loss)	(172)	(78)	(714)
Settlement / divestiture / other loss	(454)	(1,079)	(67)
Amortization of prior service cost	42	38	(1,067)
Total recognized in Other comprehensive income	$ (1,076)	$ 1,040	$ (13,248)

Benefit Plans - Accumulated Oth

Benefit Plans - Accumulated Other Comprehensive Income (Details) - All Pension Benefits - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Net actuarial loss	$ 49,917	$ 61,573
Prior service income	(122)	(81)
Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax, Total	$ 49,795	$ 61,492

Benefit Plans - Key Economic As

Benefit Plans - Key Economic Assumptions (Details) - All Pension Benefits	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Weighted-average discount rate, benefit obligation	4.80%	4.40%
Weighted-average discount rate, net periodic benefit cost	4.40%	4.60%	2.20%
Weighted-average expected return on plan assets, net periodic benefit cost	5.10%	5%	4.80%
Foreign Plan
Defined Benefit Plan Disclosure [Line Items]
Weighted-average discount rate, benefit obligation	3.70%	3.90%
Weighted-average rate of increase in compensation levels for active foreign plans	3.10%	3.10%
Weighted-average discount rate, net periodic benefit cost	3.90%	4.30%	1.90%
Weighted-average expected return on plan assets, net periodic benefit cost	4.40%	4.10%	3.20%
Weighted-average rate of increase in compensation levels for active foreign plans, net periodic benefit cost	3.10%	3.20%	3.20%

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total debt	$ 1,085,000
Current portion of long-term debt	(15,000)	$ 0
Unamortized deferred financing fees	(9,900)
Other Assets
Debt Instrument [Line Items]
Unamortized deferred financing fees	(600)
Long-term Debt
Debt Instrument [Line Items]
Total debt	1,085,000	1,019,500
Current portion of long-term debt	(15,000)	0
Unamortized deferred financing fees	(9,261)	(1,443)
Long-term debt	1,060,739	1,018,057
Senior Note Offering | Senior Notes
Debt Instrument [Line Items]
Total debt	700,000	0
Term loans | The Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Total debt	385,000	987,500
Term loans | The Credit Agreement | Senior Notes
Debt Instrument [Line Items]
Total debt	700,000
Revolving credit facility | The Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Total debt	$ 0	$ 32,000

Debt - Narrative (Details)

Debt - Narrative (Details) - USD ($)		12 Months Ended
	Apr. 04, 2022	Dec. 31, 2024	Apr. 09, 2024	Dec. 31, 2023	Jun. 28, 2022
Debt Instrument [Line Items]
Letters of credit outstanding amount		$ 27,200,000
Unamortized deferred financing fees		9,900,000
Total debt		1,085,000,000
Other Assets
Debt Instrument [Line Items]
Unamortized deferred financing fees		600,000
Long-term Debt
Debt Instrument [Line Items]
Unamortized deferred financing fees		9,261,000		$ 1,443,000
Total debt		$ 1,085,000,000		1,019,500,000
Enovis Corporation
Debt Instrument [Line Items]
Cash consideration	$ 1,200,000,000
The Credit Agreement
Debt Instrument [Line Items]
Indebtedness incurred	$ 1,200,000,000
Weighted-average interest rate (as a percent)		5.24%
The Credit Agreement | Minimum | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.125%
The Credit Agreement | Minimum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.125%
The Credit Agreement | Maximum | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.75%
The Credit Agreement | Maximum | Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.75%
Senior Note Offering | Senior Notes
Debt Instrument [Line Items]
Principal amount			$ 700,000,000
Stated interest rate			6.25%
Total debt		$ 700,000,000		0
Revolving credit facility | The Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 750,000,000
Indebtedness incurred	200,000,000
Proceeds from Long-Term Lines of Credit		750,000,000
Line of credit facility, remaining borrowing capacity		750,000,000
Total debt		0		32,000,000
Term loans | The Credit Agreement | Senior Notes
Debt Instrument [Line Items]
Principal amount	$ 600,000,000				$ 600,000,000
Debt term (in days)	364 days
Indebtedness incurred	$ 600,000,000
Term loans | The Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Principal amount	400,000,000
Indebtedness incurred	400,000,000
Total debt		385,000,000		$ 987,500,000
Term loans | The Credit Agreement | Senior Notes
Debt Instrument [Line Items]
Total debt		700,000,000
Letter of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		107,000,000
Letter of Credit | The Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	300,000,000
Letter of Credit | Uncommitted Credit Line
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 50,000,000
Swing Line Loan Sub-Facility | The Credit Agreement | Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 50,000,000

Debt - Schedule of Debt Maturit

Debt - Schedule of Debt Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
46022	$ 15,000
46387	20,000
46752	350,000
47118	0
47483	700,000
Long-term debt	1,085,000
Unamortized deferred financing fees	9,900
Long-term Debt
Debt Instrument [Line Items]
Long-term debt	1,085,000	$ 1,019,500
Unamortized deferred financing fees	$ 9,261	$ 1,443

Derivatives - Narratives (Detai

Derivatives - Narratives (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)	Aug. 22, 2024 USD ($) agreement	Aug. 22, 2024 EUR (€) agreement	Jun. 25, 2024 agreement	Dec. 31, 2023 USD ($)	Jul. 22, 2022 agreement	Jul. 14, 2022 USD ($) agreement
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Increase derivative assets and liabilities	$ 0.4
Designated as Hedging Instrument | Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount			$ 100	€ 90
Interest rate swap agreement(s)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivative instruments held | agreement								2
Notional amount	300							$ 600
Fixed interest rate								3.293%
Loss related to interest rate swap agreements	0.7
Interest rate swap agreement(s) | Cash Flow Hedging
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Proceeds From Derivative Instrument, Operating Activities	5.5
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	$ 5.5
Interest rate swap agreement(s) | Minimum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Basis spread on variable rate (as a percent)	1.25%	1.25%						1.125%
Interest rate swap agreement(s) | Maximum
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Basis spread on variable rate (as a percent)								1.75%
Cross-currency swap agreements
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivative instruments held | agreement			2	2	4		2
Cross-currency swap agreements | Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 275	€ 270
Cross-currency swap agreements | Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 178.7					$ 232.5

Derivatives - Summary of the Ef

Derivatives - Summary of the Effects of Designated Cash Flow Hedges on the Company’s Consolidated and Combined Statements of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Interest rate swap agreement(s) | Interest expense and other, net
Derivative Instruments and Hedging Activities Disclosures [Line Items]
(Gain) recognized in the Consolidated and Combined Statements of Operations	$ (9,104)	$ (11,053)

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Values of Derivative Instruments in the Financial Statements (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Liabilities	$ 1,830	$ 22,232
Other Assets	842	9,522
Cross-currency swap agreements
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Other Liabilities	1,830	22,232
Other Assets	0	0
Interest rate swap agreement(s)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Realized loss	(4,687)	(4,779)
Other Liabilities	0	0
Other Assets	$ 842	$ 9,522

Derivatives - Derivatives Not D

Derivatives - Derivatives Not Designated as Hedging Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Foreign currency contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative liability, current	$ 379	$ 596
Derivative asset, current	$ 255	$ 1,088

Derivatives - Not Designated as

Derivatives - Not Designated as Hedging Instruments (Details) - Cross-currency swap agreements - Not Designated as Hedging Instrument - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Change in unrealized (loss) gain	$ (616)	$ (1,023)	$ 1,338
Realized loss	$ 1,490	$ (2,928)	$ (17,601)

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Hierarchy (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets:
Cash equivalents	$ 8,990	$ 6,027
Deferred Compensation Plan Assets	5,242	3,488
Total assets at fair value	15,731	21,298
Liabilities:
Deferred compensation plans	5,242	3,488
Total liabilities at fair value	7,853	27,489
Cross-currency swap agreements | Not Designated as Hedging Instrument
Assets:
Derivative Asset	657	2,261
Liabilities:
Derivative liabilities	781	1,769
Cross-currency swap agreements | Designated as Hedging Instrument
Liabilities:
Derivative liabilities	1,830	22,232
Interest rate swap agreement(s)
Assets:
Derivative Asset	842	9,522
Level One
Assets:
Cash equivalents	8,990	6,027
Deferred Compensation Plan Assets	0	0
Total assets at fair value	8,990	6,027
Liabilities:
Deferred compensation plans	0	0
Total liabilities at fair value	0	0
Level One | Cross-currency swap agreements | Not Designated as Hedging Instrument
Assets:
Derivative Asset	0	0
Liabilities:
Derivative liabilities	0	0
Level One | Cross-currency swap agreements | Designated as Hedging Instrument
Liabilities:
Derivative liabilities	0	0
Level One | Interest rate swap agreement(s)
Assets:
Derivative Asset	0	0
Level Two
Assets:
Cash equivalents	0	0
Deferred Compensation Plan Assets	5,242	3,488
Total assets at fair value	6,741	15,271
Liabilities:
Deferred compensation plans	5,242	3,488
Total liabilities at fair value	7,853	27,489
Level Two | Cross-currency swap agreements | Not Designated as Hedging Instrument
Assets:
Derivative Asset	657	2,261
Liabilities:
Derivative liabilities	781	1,769
Level Two | Cross-currency swap agreements | Designated as Hedging Instrument
Liabilities:
Derivative liabilities	1,830	22,232
Level Two | Interest rate swap agreement(s)
Assets:
Derivative Asset	842	9,522
Level Three
Assets:
Cash equivalents	0	0
Deferred Compensation Plan Assets	0	0
Total assets at fair value	0	0
Liabilities:
Deferred compensation plans	0	0
Total liabilities at fair value	0	0
Level Three | Cross-currency swap agreements | Not Designated as Hedging Instrument
Assets:
Derivative Asset	0	0
Liabilities:
Derivative liabilities	0	0
Level Three | Cross-currency swap agreements | Designated as Hedging Instrument
Liabilities:
Derivative liabilities	0	0
Level Three | Interest rate swap agreement(s)
Assets:
Derivative Asset	$ 0	$ 0

Equity - Accumulated Other Comp

Equity - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 1,647,657	$ 1,388,458	$ 2,501,728
Other comprehensive (loss) income before reclassifications:
Foreign currency translation adjustment	(108,472)	47,258	(175,719)
Ending balance	1,808,249	1,647,657	1,388,458
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	(1,706)
Accumulated Other Comprehensive Loss
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(624,272)	(674,988)	(460,888)
Other comprehensive (loss) income before reclassifications:
Amounts contributed by Former Parent			(59,263)
Net actuarial gain	9,069	8,969	113
Foreign currency translation adjustment	(121,101)	(23,307)	(88,975)
Gain (loss) on long-term intra-entity foreign currency transactions	14,136	70,428	(83,105)
Unrealized gain on cash flow hedges	4,426	4,834	10,782
Other comprehensive (loss) income before reclassifications	(93,470)	60,924	(220,448)
Amounts reclassified from Accumulated other comprehensive loss	(10,126)	(10,208)	6,348
Net current period Other comprehensive income (loss)	(105,302)	50,716	(214,100)
Ending balance	(729,574)	(624,272)	(674,988)
Net Unrecognized Pension and Other Post-Retirement Benefit Cost
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(59,805)	(63,847)	(21,196)
Other comprehensive (loss) income before reclassifications:
Amounts contributed by Former Parent			(50,504)
Net actuarial gain	9,069	8,969	113
Foreign currency translation adjustment	530	(3,285)	1,712
Gain (loss) on long-term intra-entity foreign currency transactions	0	0	0
Unrealized gain on cash flow hedges	0	0	0
Other comprehensive (loss) income before reclassifications	9,599	5,684	(48,679)
Amounts reclassified from Accumulated other comprehensive loss	(146)	(1,642)	6,028
Net current period Other comprehensive income (loss)	9,453	4,042	(42,651)
Ending balance	(50,352)	(59,805)	(63,847)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	0
Foreign Currency Translation Adjustment
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(554,622)	(613,907)	(439,692)
Other comprehensive (loss) income before reclassifications:
Amounts contributed by Former Parent			(8,759)
Net actuarial gain	0	0	0
Foreign currency translation adjustment	(137,599)	(11,143)	(82,351)
Gain (loss) on long-term intra-entity foreign currency transactions	14,136	70,428	(83,105)
Unrealized gain on cash flow hedges	0	0	0
Other comprehensive (loss) income before reclassifications	(123,463)	59,285	(174,215)
Amounts reclassified from Accumulated other comprehensive loss	0	0	0
Net current period Other comprehensive income (loss)	(125,169)	59,285	(174,215)
Ending balance	(679,791)	(554,622)	(613,907)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	(1,706)
Net Investment Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(17,215)	(8,336)	0
Other comprehensive (loss) income before reclassifications:
Amounts contributed by Former Parent			0
Net actuarial gain	0	0	0
Foreign currency translation adjustment	15,968	(8,879)	(8,336)
Gain (loss) on long-term intra-entity foreign currency transactions	0	0	0
Unrealized gain on cash flow hedges	0	0	0
Other comprehensive (loss) income before reclassifications	15,968	(8,879)	(8,336)
Amounts reclassified from Accumulated other comprehensive loss	0	0	0
Net current period Other comprehensive income (loss)	15,968	(8,879)	(8,336)
Ending balance	(1,247)	(17,215)	(8,336)
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	0
Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	7,370	11,102	0
Other comprehensive (loss) income before reclassifications:
Amounts contributed by Former Parent			0
Net actuarial gain	0	0	0
Foreign currency translation adjustment	0	0	0
Gain (loss) on long-term intra-entity foreign currency transactions	0	0	0
Unrealized gain on cash flow hedges	4,426	4,834	10,782
Other comprehensive (loss) income before reclassifications	4,426	4,834	10,782
Amounts reclassified from Accumulated other comprehensive loss	(9,980)	(8,566)	320
Net current period Other comprehensive income (loss)	(5,554)	(3,732)	11,102
Ending balance	1,816	$ 7,370	$ 11,102
Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests	$ 0

Equity - Narratives (Details)

Equity - Narratives (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions	3 Months Ended	12 Months Ended
	Mar. 29, 2024	Dec. 31, 2024	Aug. 13, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Repurchase Program, Authorized, Number of Shares			5
Common stock, par value (in dollars per share)		$ 0.001		$ 0.001
Stock repurchase program, authorized amount		$ 0
Stock-based compensation expenses	$ 700
Unrecognized stock-based compensation expense related to stock options		2,400
Fair value of vested shares		10,700
Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses		$ 2,700
Performance Shares And Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, period for recognition (in years)		1 year 9 months 18 days
Unrecognized stock-based compensation expense		$ 18,500
PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses		$ 5,700
Award performance period		3 years
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance vesting period (in years)		3 years
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expenses		$ 11,400
Maximum | Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum term (in years)		10 years

Equity - PRSU and RSU Activity

Equity - PRSU and RSU Activity (Details)	12 Months Ended
	Dec. 31, 2024 $ / shares shares
PRSUs
Number of Units
Number of units, nonvested, beginning balance (in shares) | shares	143,875
Granted (in shares) | shares	(56,767)
Vested (in shares) | shares	0
Forfeited and expired (in shares) | shares	0
Number of units, nonvested, ending balance (in shares) | shares	200,642
Weighted- Average Grant-Date Fair Value
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares	$ 55.86
Awards converted from Former Parent plan (in usd per share) | $ / shares	100.33
Granted (in usd per share) | $ / shares	0
Vested (in usd per share) | $ / shares	0
Forfeited and expired (in usd per share) | $ / shares	$ 68.44
RSUs
Number of Units
Number of units, nonvested, beginning balance (in shares) | shares	464,730
Granted (in shares) | shares	(122,155)
Vested (in shares) | shares	(191,802)
Forfeited and expired (in shares) | shares	(21,463)
Number of units, nonvested, ending balance (in shares) | shares	373,620
Weighted- Average Grant-Date Fair Value
Weighted-average grant date fair value, nonvested, beginning balance (in usd per share) | $ / shares	$ 55.21
Awards converted from Former Parent plan (in usd per share) | $ / shares	95.23
Granted (in usd per share) | $ / shares	56.54
Vested (in usd per share) | $ / shares	65.79
Forfeited and expired (in usd per share) | $ / shares	$ 67.02

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Future claims period (in years)	15 years
Unconditional purchase obligation	$ 143.3

Commitments and Contingencies_2

Commitments and Contingencies - Claims Rollforward (Details)	12 Months Ended
	Dec. 31, 2024 USD ($) claim	Dec. 31, 2023 USD ($) claim
Loss Contingency Accrual [Roll Forward]
Claims unresolved, beginning of period	13,648	14,106
Claims filed	5,005	4,627
Claims resolved	(4,895)	(5,085)
Claims unresolved, end of period	13,758	13,648
Average cost of resolved claims | $	$ 10,574	$ 9,524

Commitments and Contingencies_3

Commitments and Contingencies - Asbestos Litigation (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Long-term asbestos insurance asset	$ 234,951	$ 221,489
Long-term asbestos insurance receivable	16,961	17,868
Accrued asbestos liability	40,779	32,908
Asbestos liability	$ 253,287	$ 234,796

Segment Information - Narrative

Segment Information - Narratives (Details)	12 Months Ended
	Dec. 31, 2024 segment
Segment Reporting [Abstract]
Number of reportable segments	2

Segment Information - Segment R

Segment Information - Segment Reporting Information, by Segment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 2,740,803	$ 2,774,766	$ 2,593,480
Cost of sales	1,703,348	1,759,015	1,707,950
Gross profit	1,037,455	1,015,751	885,530
Allocated corporate overhead operating expense:	162,324	168,652	140,855
Other operating expense:	346,357	345,997	307,921
Adjusted EBITDA	528,774	501,102	436,754
Depreciation, amortization and other impairment charges:	67,171	75,034	65,978
Capital expenditures:	51,779	48,178	40,243
Net income from continuing operations	293,057	223,365	231,081
Income tax expense	77,348	95,727	69,170
Interest expense and other, net	64,890	85,074
Interest income and other, net			37,950
Pension settlement loss (gain)	12,155	0	(9,136)
Restructuring and other related charges	10,227	24,110	23,096
Separation costs	0	0	15,545
Acquisition - amortization and other related charges	34,479	36,851	34,196
Depreciation and other amortization	36,618	35,975	34,852
Investments in equity method investees:	28,885	30,633
Total assets:	4,033,975	3,828,629
United States
Segment Reporting Information [Line Items]
Net sales	595,600	619,100	583,000
Americas Segment [Member]
Segment Reporting Information [Line Items]
Net sales	1,176,745	1,214,998	1,128,306
Cost of sales	711,082	760,134	752,641
Allocated corporate overhead operating expense:	64,517	64,668	55,328
Other operating expense:	161,946	165,454	131,760
Adjusted EBITDA	239,200	224,742	188,577
Depreciation, amortization and other impairment charges:	31,193	34,589	29,281
Capital expenditures:	22,648	21,576	18,005
Investments in equity method investees:	0	0
Total assets:	1,796,167	1,671,634
EMEA and APAC Segment [Member]
Segment Reporting Information [Line Items]
Net sales	1,564,058	1,559,768	1,465,174
Cost of sales	992,266	998,881	955,309
Allocated corporate overhead operating expense:	97,807	103,984	85,527
Other operating expense:	184,411	180,543	176,161
Adjusted EBITDA	289,574	276,360	248,177
Depreciation, amortization and other impairment charges:	35,978	40,445	36,697
Capital expenditures:	29,131	26,602	$ 22,238
Investments in equity method investees:	28,885	30,633
Total assets:	$ 2,237,808	$ 2,156,995

Segment Information - Net Sales

Segment Information - Net Sales and PPE by Geography (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 298,347	$ 294,305
United States
Segment Reporting Information [Line Items]
Property, plant and equipment, net	73,036	68,398
Czech Republic
Segment Reporting Information [Line Items]
Property, plant and equipment, net	55,554	60,948
India
Segment Reporting Information [Line Items]
Property, plant and equipment, net	31,506	31,258
Russia
Segment Reporting Information [Line Items]
Property, plant and equipment, net	12,225	15,550
Mexico
Segment Reporting Information [Line Items]
Property, plant and equipment, net	20,495	23,922
Poland
Segment Reporting Information [Line Items]
Property, plant and equipment, net	17,227	14,661
Other foreign countries
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 88,304	$ 79,568

Related Party Transactions (Det

Related Party Transactions (Details) - Related Party - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Apr. 01, 2022	Dec. 31, 2024
License Of Improvements
Related Party Transaction [Line Items]
Related party transaction, period		2 years
Allocated Expenses From Former Parent
Related Party Transaction [Line Items]
Allocated expenses	$ 6

Subsequent Events (Details)

Subsequent Events (Details) $ in Thousands, € in Millions			12 Months Ended
	Feb. 18, 2025 EUR (€)	Jan. 17, 2025 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Subsequent Event [Line Items]
Dividends payable			$ 4,900
Dividends paid			$ 16,992	$ 13,342	$ 6,054
Subsequent Event
Subsequent Event [Line Items]
Dividends paid		$ 4,900
Subsequent Event | Bavaria Schweisstechnik
Subsequent Event [Line Items]
Purchase price | €	€ 60

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Charged to Expense, net	$ 2,248
Valuation allowance on deferred taxes	(12,500)
Transferred From Former Parent
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Valuation allowance on deferred taxes			$ 68,900
Allowance for credit losses
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	25,477	$ 23,471	23,912
Charged to Expense, net	2,248	3,902	4,526
Write-Offs Write-Downs Deductions and Other	(2,423)	(2,289)	(4,978)
Foreign Currency Translation	(1,452)	393	11
Balance at End of Period	23,850	25,477	23,471
Valuation allowance for deferred tax assets
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	79,355	88,202	15,465
Charged to Expense, net	(761)	(12,283)	4,503
Write-Offs Write-Downs Deductions and Other	(12,478)	0	68,876
Foreign Currency Translation	(1,109)	3,426	(642)
Balance at End of Period	$ 65,007	$ 79,355	$ 88,202